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3Abstract
Bone is a fibrous nanocomposite material with a complex hierarchical system of different
macro-, micro- and nanostructures. The structure elegantly supports the bone cell functions
and facilitates bone remodeling by cellular activity. Injuries and diseases, e.g. osteoporosis,
can cause bone fractures and loss that need to be treated with orthopedic implants. The
global orthopedic market was estimated at $30 500 000 000 in 2012 and predicted to grow
rapidly. A substantial amount of this goes to revision surgery due to implant failures. This
not only causes unnecessary costs and work but reduces the quality of life for patients. The
key for improving the performance of current implants lies in optimizing both the surface
chemistry and structure from macro- to nanoscale. At best bone defects can be treated with
bone scaffolds that induce formation of new bone via cellular functions and are degraded
by the body thus evading the need for implant removal surgery. However, combining the
favorable mechanical, structural and chemical properties poses challenges for the design
and preparation methods used for bone implants and scaffolds.
The aim of this work was to investigate the preparation of thin film and fibrous biomaterials
for bone implants and scaffolds. New processes were developed for various biomaterials
and their properties were thoroughly characterized. A method to convert CaCO3
nanostructures to nanocrystalline hydroxyapatite (HA) by treatment in phosphate solution
was used to prepare HA thin films and fibers from atomic layer deposited (ALD) and
electrospun CaCO3, respectively. HA fibers were also fabricated conventionally by
annealing electrospun composite fibers that incorporated Ca and P precursors.
Biocomposite fibers of HA nanoparticles and polylactic acid (nHA/PLA) were directly
electrospun. These different nanofibers are highly interesting for bone scaffolds owing to
their high surface area and the structural similarity to the fibrous nanostructure found in
bone. However, conventional electrospinning is limited by its modest production rate. A
needleless twisted wire electrospinning (NTWE) setup was developed to increase the
production rate and was studied for the preparation of HA fibers for the bone scaffolds.
Solution blow spinning (SBS) and electroblowing (EB) of HA were studied as other
upscaling alternatives.
Promising results were obtained in cell culture studies with the different materials. The
electrospun materials could find use in fibrous bone scaffolds. The HA fibers were found
out to be very interesting from a biological standpoint, but the fragility of the fibers limits
their usability as such and therefore methods to incorporate bioceramic fibers into more
rigid support structures should be developed. The method to prepare nanocrystalline HA by
the conversion of CaCO3 proved to be highly conformal as evidenced by its ability to
preserve the original shape of the ALD films and electrospun fibers. NTWE and EB were
shown to be capable of producing high quality nanofibers and to provide a viable upscaling
route to conventional electrospinning. In contrast, the quality of the SBS fibers needs
improvement. Further work would be required to conclude if EB and NTWE are upscalable
to industrial scale production levels.
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1 Introduction
Bone has unique properties owing to its complex hierarchical structure from macro- to
nanoscale. It has exceptional mechanical properties relative to its weight and is under
constant remodeling cycle that results in complete renewal of 10 % of adult bone tissue
yearly.1 These properties are based on highly ordered nanostructures of carbonated
hydroxyapatite (CHA) crystals and collagen molecules that form the building blocks of bone
tissue; the collagen fibrils.2 These in turn are ordered into different macrostructures that are
optimized to provide necessary mechanical strength and enable vascularization and nutrient
transport inside the tissue.
Loss or failure of bone can occur due to multiple reasons such as bone diseases, e.g.
osteoporosis and cancer, and injuries. The global orthopedic market was estimated at
$30 500 000 000 in 2012 and predicted to grow rapidly.3 Metal implants, especially titanium
and titanium alloys, are widely used in orthopedic surgery owing to their biocompatibility
and high mechanical strength relative to their weight. However, sometimes implant failures
occur due to poor integration of the implant with host tissue. For example 7 % of all joint
replacements are performed only to replace a failed implant.1 The key for optimal biological
integration of an implant with the host bone tissue lies in the chemical interaction with the
environment and nano- and microstructural features at the surface of the implant. Bioactive
coatings are used on implants to optimize the chemical and structural environment. The
coating should enable similar cellular functions as the host bone tissue and lead to a strong
bonding of the surface to the host tissue via cellular activity. Bone scaffolds offer further
improvement from bioinert bone implants especially in implant sites with less demanding
mechanical requirements. A bone scaffold is a support structure that is incorporated in the
bone remodeling cycle.4 The scaffold facilitates new bone ingrowth while degrading at the
same time and is eventually fully replaced by new bone and thus no implant removal surgery
is required.
The aim of this work was to evaluate and develop methods to prepare nanostructural
materials that would exhibit optimized biological response in bone tissue and could be later
on be incorporated into bone implants and scaffolds. A literature survey about preparation
of bioactive coatings by atomic layer deposition (ALD) and fibrous biocomposites and
bioceramics (including bioactive glasses) by electrospinning was conducted. Additionally,
needleless electrospinning, solution blow spinning (SBS) and electroblowing (EB)
techniques were reviewed as a higher productivity alternative to conventional
electrospinning.
ALD is a gas phase thin film deposition method that is capable of producing highly
conformal films with atomic layer thickness control.5, 6 Thus it is very interesting for coating
of implants and scaffolds with nanostructural features. However, in the literature review
only a few studies targeted towards these applications were found. In this work a new
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process was added to this field, in which ALD calcium carbonate (CaCO3) thin films were
converted to biomimetic nanocrystalline hydroxyapatite (HA) thin films.
Electrospinning is a straightforward method that is capable of preparing long continuous
fibers with diameters down to the nanoscale.7, 8 Due to the high surface area, porosity and
structural similarity with fibrous bone tissue, electrospinning is a highly prosperous method
for preparation of fibrous bone scaffolds. The literature survey presented in this thesis shows
that a wide variety of electrospun biocomposite and bioceramic fiber materials have shown
great promise for the bone scaffold applications. Specific attention was put on the
bioceramic fibers and especially hydroxyapatite due to its similarity with the bone mineral,
as they have thus far been less comprehensively studied compared to the very established
field of electrospun biocomposites. Although fragility limits their usage, they have shown
great promise from a biological standpoint.
In this thesis the preparation and properties of various fibrous biomaterials were examined.
Electrospinning was used to prepare biocomposite (hydroxyapatite nanoparticles/polylactic
acid, nHA/PLA) and bioceramic (HA, CaCO3) nanofibers. Nanocrystalline HA fibers were
prepared by the solution conversion of the electrospun CaCO3 fibers. This process was also
combined with spin and dip coating and ALD of CaCO3 films to produce high surface area
fibrous nanocrystalline HA coatings. Needleless electrospinning from a twisted wire
(NTWE), SBS and EB were examined for upscaling the productivity of conventional needle
electrospinning for the preparation of HA nanofibers.
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2 Bone structure and remodeling
Bone is the main supportive organ of the human body and an important reservoir of
minerals.9 It is a complex heterogeneous material of different hierarchical structures from
macro- to nanostructural level (Figure 1A).1, 2, 10-12 Up to nine different hierarchical levels
can be identified and for a comprehensive description of all of them the reader is referred to
the excellent review by Reznikov et al.2 Bone macrostructure can be divided into two main
types; cortical (also referred as compact or dense) bone and cancellous (also referred as
spongy or trabecular) bone that occupy 80 and 20 % of the total bone mass, respectively.9
Cancellous bone is more porous (50-90 %)13 and disordered of the two and is incorporated
with a high concentration of blood vessels. Cortical bone is ordered into cylindrical pillars
called osteons, is dense (porosity of 3-12 %)13, and forms the outer shell of bone shielding
the sponge-like cancellous bone interiors and providing most of the mechanical strength of
bone.1, 9
The main components of bone are collagen and carbonated hydroxyapatite (CHA). Both
cancellous and cortical bone consist mainly of collagen fibrils that in turn have an ordered
nanocomposite structure where individual collagen molecules (diameter ~1.5 nm and length
~300 nm) form a periodic structure having 67 nm spacing and 40 nm gaps between
successive molecules and plate-like apatite nanocrystals (~3 x 25 x 50 nm3) reside in the
gaps as depicted in Figure 1B.10 A large part of the apatite present in bone also resides
between the individual fibrils (Figure 1C),2, 14 and have a plate-like nanocrystal structure
(~5 x 70 nm2 and several hundred nm long) similarly to the crystals occupying the hole
zones inside the fibrils.14
The composite structures of CHA and collagen give bone extraordinary mechanical
properties in respect to the weight of the material. There are large variations in the values
reported in literature for the mechanical properties of the cortical and cancellous bone as
they are dependent on multiple factors. Generally, cortical bone is significantly stronger
material compared to cancellous bone. At the macrostructural level cancellous bone
typically has the strength between 0.1 to 30 MPa and Young’s modulus from 0.01 to 2 GPa
depending on factors such as loading direction, porosity, site and the age/health of the
person.15 Cortical bone has been reported to have tensile strength in the range of 50-
150 MPa and Young’s modulus of 7-30 MPa.9
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(A) The hierarchical structure of bone from macro- to nanosctructure, (B) the
nanostructure of an individual collagen fibril showing the dimensions of the stacked
repeating structure of collagen fibers and the CHA crystals embedded in the hole zones, and
(C) a simplified model of bone mineral embedded between the collagen fibrils in bone.
Figure A reproduced from [1], with the permission of AIP Publishing, Copyright (2015).
Figure B reprinted from [10] with permission from Elsevier, Copyright (1998). Figure C
reprinted from the open-access article [14] under the terms of the Creative Commons
Attribution License.
Bone is a dynamic structure that can modify its shape and size according to mechanical
stress.12, 16 Bone is also in a constant remodeling cycle where it is resorbed by the bone-
removing cells, i.e. osteoclasts, and new bone is produced by the bone-forming cells, i.e.
osteoblasts (Figure 2).9, 12, 17-19 In an adult body ~10 % of bone is renewed every year.1, 12
The remodeling cycle is regulated by various factors and chemical cues, e.g. cytokines,
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hormones and mechanical loads.12, 18, 20 The process begins with an activation phase during
which mononuclear pre-osteoblasts fuse into multinuclear osteoclasts at the bone surface.
In the following resorption phase the osteoclasts seal the area underneath the cells and
release hydrogen ions to that area dissolving bone and producing a resorption lacunae. The
resorption phase is coupled with the new bone formation phase. Pre-osteoblasts populate
the resorption lacuna and differentiate into osteoblasts that form new bone at the site. During
new bone formation some osteoblasts are terminally differentiated and buried in the bone
matrix as osteocytes while some osteoblasts differentiate into bone lining cells at the surface
of the newly formed bone matrix.
The bone remodelling cycle. Reprinted from [12] by permission of Oxford
University Press, Copyright (2009).
16
3 Bioactive coatings
Metallic implants, especially titanium and its alloys, are widely used in bone surgery. Their
mechanical strength, durability and biocompatibility make them well suited for applications
with high mechanical loads, e.g. screws and pins for treating bone fractures.3 However, as
such titanium surfaces are not biologically very active and do thus not bond effectively with
the bone tissue. This can lead to loosening at the bone-implant interface and eventual failure
of the implant. Bioactive coatings are used to modify the surface chemistry of the implant
to better support cell functions that lead to better implant-to-bone bonding, i.e.
osseointegration.21, 22 Bioactive coatings can also be applied on three dimensional scaffold
structures to enhance the cell functions at the interfaces, e.g. biomimetic HA coatings on
electrospun biopolymers that will be discussed in the following sections.
As well as the surface chemistry, the micro- and nanotopographies at the interface are
important for the optimal interaction of a bioactive surface with the bone tissue and cells.19,
21, 23-25 Physical treatments, for example grit-blasting and etching, are often employed to
enhance the surface roughness of metal implants and have been shown to lead to improved
bioactivity.23, 26-28 Microroughness generates a high surface area for increased bone
anchorage and mechanical locking. Nanoroughness enhances cell attachment, migration and
proliferation. Thus the optimization of both the topography and chemical environment are
essential for the best possible osseointegration of the implant.29 Additionally the coatings
need to have sufficient adhesion as delamination can lead to not only mechanical failure,
but also into inflammatory reactions.
The bioactive property of any surface can be evaluated by in vitro immersion studies in
simulated body fluid (SBF) in which apatite formation is usually observed on bioactive
surfaces.30 Still, SBF studies can in some circumstances produce false positive or negative
results and thus in vivo studies are always required for definitive evaluation of the
bioactivity of a scaffold.31 Another way to classify scaffolds is by their ability to support
bone cell functions. Osteoconductive materials support the bone cell functions leading to
new bone formation whereas osteoinductive materials also induce stem cell differentiation
into bone cells.32, 33 Cell culture studies are used to determine the osteoconductive
and -inductive properties, e.g. cell activity, viability, proliferation and differentiation. For
example the differentiation into osteoblasts can be studied by the expression of bone specific
markers such as osteopontin and osteocalcin, and by alkaline phosphatase (ALP) activity.
In comparison, osteoclast activity is most commonly studied by tartrate-resistant acid
phosphatase (TRAP) activity.
Some common inorganic bioactive coating materials include TiO2, calcium phosphates, e.g.
HA, β-tricalcium phosphate (β-TCP), CHA and Si doped HA, and bioactive glasses.34-57
TiO2 is an interesting material due to its excellent integration with metallic titanium. Thus
TiO2 is less likely to suffer from delamination or other kind of mechanical failures. For
example, anodization has been used to grow nanotubular TiO2 on Ti and shown to promote
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bone cell functions leading to better osseointegration.44, 45 Calcium phosphates in turn are
interesting coating materials due to their chemical similarity with the bone tissue. Many
techniques (e.g. plasma-spraying, pulsed laser deposition, sputtering, sol-gel and
biomimetic method) have been used to deposit HA coatings on metal implants.34-43 Plasma-
spraying is clinically the most widely adopted method and plasma-sprayed HA coatings
have been shown to lead to a more rapid fixation and stronger bonding between the implant
and bone tissue.34 However, plasma sprayed HA coatings have also several limitations. The
coatings incorporate micropores and -cracks and contain also impurity phases.41, 42, 52, 58
These can lead to dissolution and/or delamination and subsequent inflammatory reactions
as well as loosening. The coatings are also quite thick (~50 μm) and thus the method cannot
preserve any possible cell guiding micro- and nanotopographic surface modifications of the
underlying implant. As a line of sight method plasma spraying is also inapt for coating
complex geometries, e.g. implants with porous three-dimensional structures. Similar
limitation applies also to other physical vapor deposition type of techniques.
3.1 Atomic layer deposition of bioactive coatings
Atomic layer deposition is a thin film deposition method based on sequential pulsing of gas
phase precursors on a substrate separated by inert gas purges.5, 6 Self-limiting reactions at
the surface result in a film growth limited by the number of the precursor cycles rather than
precursor doses as long as the pulses are sufficient for saturative reactions at the surface.
Thus the film thickness can be controlled down to the atomic level simply the number of
cycles. Due to the self-limiting growth mechanism it can be used to conformally coat very
demanding three-dimensional nanostructures by high quality pin-hole free films. This
ability makes bioactive ALD coatings highly interesting for demanding three-dimensional
implants and scaffolds e.g. fibrous scaffolds.
The ALD method has unique characteristics that make it an interesting prospect for coating
of bone implants and scaffolds. Aside from the chemical properties of a surface, its
topography plays an important role in osseointegration of implants.21, 23 ALD can be used
to produce a favorable chemical surface for cell interactions while preserving the
topography of the substrate that can be used to further guide cell response. No other method
is capable of producing coatings with similar conformality paired with atomic level
thickness control.
ALD has gained some interest in many fields of biomedicine, but very little effort has been
directed towards implant coatings comprehensively summarized in a review by Skoog et
al.59 Although multiple ALD processes are known for several biocompatible materials,
studies on use as implant coatings are rare. Coating of polymeric templates and scaffolds on
the other hand is limited also by the thermal durability of biopolymers. There are ALD
processes that can be run even at room temperature, but the ALD processes that operate at
temperatures over 200 °C are above the melting points of the most common biopolymers
e.g. PLA, polycaprolactone (PCL), polylactic-co-glycolic acid (PLGA), collagen (Col),
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gelatin (Gel) and chitosan (CTS). The possibility of increasing bioactivity of porous
polymers has anyhow been demonstrated by coating of highly porous poly(styrene-
divinylbenzene) (PS-DVB) microparticles with <10 nm of amorphous alumina and
amorphous TiO2 films.60, 61 Although alumina is generally considered a bioinert rather than
bioactive material, both TiO2 and Al2O3 coated particles showed enhanced HCA formation
in SBF compared to the bare PS-DVB.
TiO2 is among the most studied ALD materials with multiple precursor combinations
reported in literature.62-64 By a selection of the precursor combination, deposition
temperature and film thickness, i.e. cycle number, the crystallinity of the films can be tuned
from amorphous to polycrystalline anatase, rutile or brookite phases.6 Like with electrospun
TiO2 fibers almost all ALD TiO2 studies focus on other application areas for TiO2 than
bioactive coatings. ALD anatase films on planar titanium and silicon substrates have been
shown to be bioactive in SBF.65, 66 It is a common feature of ALD to deposit initially
amorphous films that crystallize with increasing cycle number. Grigal et al.66 found the
anatase phase to crystallize after 300 cycles (10.5 nm) of the titanium ethoxide-water
process at 300 °C. Thinner films were amorphous and did not show continuous apatite layer
formation in SBF. Thicker films showed more intense apatite formation that was most likely
enhanced by the increase in surface roughness with increasing thickness. Still, as the results
on the TiO2 coated PS-DVB demonstrate, crystalline film is not a prerequisite for bioactivity
as surface topography also contributes to bone bonding.61 Unfortunately there are no
bioactivity studies on ALD rutile or mixed phase TiO2 films.
For the calcium phosphates only a single direct ALD process is reported that relies on
combining Ca(thd)2/O3 and (CH3O)3PO/H2O cycles to obtain amorphous calcium phosphate
thin films.67 The Ca/P ratio in the films is controlled by the ratio of these cycles leading to
a quite sensitive and challenging process to obtain the desired composition (Figure 3). In
addition to the cycle ratio, surface roughness and film thickness have been reported to have
an effect on film composition in this process.68 Cell culture studies with MC3T3-E1 cells
showed that the amorphous calcium phosphate films with the Ca/P ratio close to
hydroxyapatite, i.e. 1.67, were biocompatible and non-dissolvable in the cell culture
medium.67, 68 Still, the long term stability of the amorphous coatings remains a concern as
amorphous calcium phosphates generally have too high dissolution rate in vivo for implant
coatings. The amorphous ALD calcium phosphate films can be crystallized to
hydroxyapatite by annealing films with the appropriate composition (Ca/P = 1.5-1.7) in
moist N2 at ≥500 °C resulting in higher osteoblast count and better osteoblast attachment
compared to the as-deposited amorphous films.67
19
Effect of Ca(thd)2/O3:(CH3O)3PO/H2O pulsing ratio to the (A) Ca/P ratio and (B)
calcium, phosphorus and carbon content in the amorphous calcium phosphate films.
Reprinted from [67] with permission from Elsevier, Copyright (2009).
20
4 Bone scaffolds
The general definition of a scaffold is a temporary support structure for cell and tissue
growth.9, 69 Thus the ideal bone scaffold should facilitate bone cell functions leading to a
rapid formation of new bone tissue while the degradation rate of the scaffold should match
that of the new tissue formation. The scaffold should also have sufficient mechanical
properties. The most vital property of any scaffold or biomaterial is the biocompatibility,
i.e. the material should not provoke excessive inflammatory response upon implantation.
Biocompatible bone implant materials can be further divided to bioinert, bioactive and also
bioresorbable. Bioinert materials are non-reactive in the physiological environment and thus
not that useful for bone scaffolds. Bioresorbable bone scaffold materials are degrading in
the body due to dissolution and/or via resorption by osteoclasts.18 The rate of the degradation
as well as the degradation products should be taken into account in scaffold design.
Scaffold performance is dependent on both structural and chemical properties of the scaffold
surfaces. Sufficient macroporosity and pore interconnectivity are essential for transport of
nutrients and growth factors as well as for the formation of blood vessels, thus allowing
bone ingrowth within the scaffold.70, 71 For this pore sizes of at least between 100-300 μm
are required. Cell attachment, proliferation and differentiation are largely dependent on
surface properties, i.e. surface chemistry and micro- and nanotopography. The scaffold
porosity is usually a compromise between the aforementioned properties and mechanical
requirements at the implantation site. Nanobiomaterials in general and especially
nanofibrous materials are highly interesting for bone scaffolds due to their high surface to
volume ratio and similarity with the extracellular matrix in bone.9, 17 As bone itself is a
hierarchical structure of different macro-, micro and nanostructures, similar features are
required also from scaffolds for optimal interaction with the host tissue and bone cells upon
implantation.33 In the following chapters the use of electrospinning and related methods to
prepare fibrous biocomposite and bioceramic scaffolds will be examined.
4.1 Electrospinning
Electrospinning is an extremely simple and straightforward method for preparation of long
fibers with diameters from micrometers down to a few nanometers. There are numerous
excellent reviews focused on the electrospinning method, and the range of electrospun
materials and their applications.7, 72-76 In its simplest form an experimental electrospinning
setup consists of a syringe pump that is used to push viscous polymer solution through a
needle set to a high voltage and a grounded collector for the fibers (Figure 4).77 However,
there are several other spinneret designs that are usually aimed for higher productivity and
will thus be further discussed in the section on the scale-up of electrospinning.
Regardless of the spinneret design the electrospinning method is based on a process where
a jet erupts from a viscous polymer solution set to a high voltage and is collected as fibers
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on a collector set to lower potential. The jet eruption occurs through a self-forming cone
known as the Taylor cone when the electrostatic forces in the solution overcome the surface
tension. The cone shape is caused by the counteracting forces as the surface tension tries to
minimize the total surface area whereas by the electrostatic repulsion tries to maximize the
distances between individual charges. During the flight of the jet the combination of the
electrostatic and viscoelastic forces result in bending instability of the jet and thus jet
elongation and thinning. For fiber formation sufficient solution viscosity is critical as the
viscoelastic forces in the erupted jet prevent it from breaking up into droplets that would
result in electrospraying of particles. Along with the viscosity the properties of electrospun
fibers are governed by multiple solution, operating and ambient parameters that are
collected in Table 1. For detailed effect of the individual parameters the reader is referred
to literature.8
Table 1. Electrospinning parameters. Collected from ref. 8.
Solution parameters Operating parameters Ambient parameters
Polymer molecular weight (Viscosity) Spinneret design Humidity
Polymer concentration (Viscosity) Voltage (Electric field) Temperature
Conductivity Distance to collector (Electric field) Atmosphere
Surface tension Solution feed rate Pressure
Dielectric constant of solvent Collector design
Vapor pressure of solvent
Conventional needle electrospinning schematic. Reprinted from the open-access
book chapter [77] published under the Creative Commons License CC BY-NC-SA 3.0.
Electrospinning can be used to prepare composites and ceramics via addition of precursors
into the polymeric solution. For ceramics an electrospun polymer is used as the host for
fiber formation that is later removed by annealing during which the other precursors in the
fiber matrix react to form the target material.76 There are also some examples where a
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viscous inorganic sol is used for direct electrospinning of inorganic fibers without the need
of a carrier polymer. However the precursors and materials available via this approach are
relatively narrow whereas by using carrier polymers the selection of available materials is
greatly expanded.
4.2 Scale-up of electrospinning
4.2.1 Multineedle and needleless electrospinning
The main limitation of the electrospinning method is the modest throughput. Conventional
single needle electrospinning can achieve production rates of only ~0.1 g/h. Addition of
multiple needles to the system does not necessarily result in linear growth of the production
rate because interfering electric fields result in suppression of electrospinning from
individual needles.78 Although the total production rate is to increase, multiple needles will
also lead to several complications such as different production rates and properties of fibers
spun from different needles with different electric fields, separate growth areas, clogging
and dripping of solution from the needles. The addition of more needles to a system quickly
leads to a very difficult process with limited advantage in production rate. Still, multineedle
devices are available also for industrial scale fiber preparation and the problems associated
with interfering electric fields can be minimized with optimized needle arrangement.79
However, various needleless designs can be considered as more viable approaches for the
production upscaling.80-85
Needleless approaches generally do not suffer from similar upscaling issues as the needle
designs because they rely on self-formation of jet initiation points on positions governed by
the electric field rather than needle placement.82 Thus simultaneous electrospinning from
multiple jets from a single surface is easily achieved. Spinnerets with tips, edges or curved
surfaces are used to concentrate the electric field to facilitate jet initiation as Taylor cones
form only on solution surfaces with sufficiently high electric field intensity. Some examples
of spinnerets from literature are presented in Figure 5.81
Electrospinning from the surfaces of cylider, disc and ball spinnerets rotating in
a solution bath. Reprinted from [81] with permission from Taylor & Francis, Copyright
(2012).
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4.2.2 Solution blow spinning
In solution blow spinning (SBS, also sometimes referred as solution blowing and air jet
spinning) a polymer solution is drawn into fibers by a high velocity gas flow (Figure 6).86-
95 SBS has not been studied much until recent years especially when compared to the
enormous number of studies performed on electrospinning. The fibers can be prepared with
coaxial aperture/needle setups and even with commercial airbrushes, sometimes referred
simply as airbrushing of fibers. Coaxial fibers have also been prepared via addition of
another solution feeding nozzle to the center, i.e. triaxial setup.96, 97 Thus far almost all SBS
studies have focused on polymeric fibers while reports on inorganics are scarce.
Formation of a polymer jet in an SBS process with a coaxial nozzle design. High
pressure (P1) gas flows through the outer nozzle generating a region of lower pressure (P2)
around the inner nozzle drawing the solution pumped through the nozzle into a cone and
subsequently into a polymer jet. Reprinted from [86] with permission from John Wiley and
Sons, Copyright (2009).
In the SBS process the gas flow rate and the temperature and composition of that gas feed
are the critical parameters for the jet initiation and elongation.86 Due to the different jet
formation process SBS can be considered as its own separate fiber preparation method rather
than just a modification of the electrospinning technique. However, apart from the
fundamental difference in the jet initiation process, the method shares most of the same
characteristics as conventional single needle electrospinning and can be thus considered also
as an upscaling direction for the conventional electrospinning processes. From the
electrospinning parameters presented in Table 1, solution conductivity, dielectric properties
and parameters related to electric field strength are naturally not affecting the SBS process,
but otherwise the rest of the solution and operating parameters and all the ambient
parameters are shared by the methods.
Even though the SBS method is very similar to electrospinning there are some
characteristics in the product that are distinctive to solution blown fiber membranes. In
electrospinning the electrostatic repulsion present in the fibers tries to maximize the
difference between individual fibers and results in randomly oriented rather homogeneous
fiber network unless the electric field. In SBS no such force is present and thus individual
fibers are commonly bundled together and the overall porosity between these bundles is
higher compared to electrospun membranes.89 Naturally it depends on the application
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whether such a morphology is favorable. Also the absence of electrostatic forces opens a
wide array of possible fiber collectors from non-conductive plastics to even live-tissue for
in situ SBS for medical applications such as wound sealing.92
4.2.3 Electroblowing
Electroblowing (EB) is a method combining needle electrospinning and SBS, i.e. fibers are
blown with the gas flow from a charged solution. The solution can be either directly set to
a high voltage or charged by electrostatic induction by blowing the solution through a
charged ring into a grounded collector (known as electrostatic-induction-assisted SBS).98
Aside from the higher feed rates permitted by the addition of high velocity gas flow, the EB
method also enables the spinning of high quality nanofibers from solutions that in
electrospinning are normally yielding only beaded fibers or are even completely non-
electrospinnable. In fact EB is referred in literature also as gas-assisted, gas-jet and blowing-
assisted electrospinning highlighting this ability.99, 100
Compared to SBS (Figure 7a), EB produces fiber membranes that are similar to electrospun
membranes, i.e. non-bundled with random orientation (Figure 7b-d).98 However, a
conductive collector set to a lower potential must be used. On the other hand the fibers are
electrostatically drawn to the collector, which concentrates the fiber deposition area and
leads to more densely packed fiber membranes.
Effect of applied voltage on EB of polyacrylonitrile (PAN); (a) 0 kV (SBS), (b)
10, (c) 20 and (d) 25 kV. Charging via an electrostatic induction ring. Reprinted from [98]
with permission from John Wiley and Sons, Copyright (2015).
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4.2.4 Comparison of the scale-up methods
From the upscaling methods presented, multineedle and needleless electrospinning methods
are the most mature techniques for the fiber preparation. For example the commercial
Elmarco Nanospider electrospinning tools employing wire and cylinder electrodes are
widely used for industrial scale nanofiber fabrication.101, 102 In contrast SBS and EB are less
established technologies and thus not yet as widely applied.
Unfortunately there are only very few studies on SBS and EB that actually report the
production rate as typically only the feed rates are given. Also, often no optimization
towards maximum production has been done. Still because similar solutions are used as in
conventional needle electrospinning the fiber production rate should linearly follow the
increase in the feed rate. Typical feed rates in electrospinning are 1-5 ml/h whereas in SBS
studies the feed rates in the range of 5-30 ml/h are commonly used (Table 2). Similarly to
the multineedle electrospinning these methods should be upscalable via the multispinneret
approach. Zhuang et al.103 demonstrated solution blowing of polyvinyl fluoride (PVDF)
using a die with 20 orifices in a linear configuration and a feed rate of 16 ml/h per orifice.
Still, the effects of multiple separate gas flows on the fiber deposition in SBS and also in
EB are largely unknown at this point. EB from multiple spinnerets could also alter the
process as compared to the single spinneret process due to the interfering electric fields
similarly as observed in the multineedle electrospinning. However, in EB the gas flow is the
main jet initiation force and thus less complications caused by the electric field interference
at the needle tip can be expected.
In an interesting concept by He et al.104 multijet EB was achieved from a single spray gun
nozzle with the aid of a mesh filter. Using this configuration the authors prepared
polyacrylonitrile (PAN) nanofibers at a production rate of 75.6 g/h. In comparison, for the
commercial Nanospider electrospinning technology values of 1.5-1.8 g/h of polyvinyl
alcohol (PVA) nanofibers per 1 meter length of spinneret cylinder were reported in the
patent by Jirsak et al.102 Later on this technology has developed into industrial scale tools
with either wire or cylinder electrodes as spinnerets. Currently the largest available
Nanospider unit (NS 8S1600U) is claimed to be capable of coating annually 20 000 000 m2
paper having a width of 1.6 m with 0.03 g/m2 nylon-6 nanofibers.101 Some interesting results
presented in literature for different upscaling approaches are collected in Table 2.
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4.3 Bioceramic and biocomposite nanofibers for bone scaffolds
There are numerous studies about the use of bare biopolymer fibers in various biomedical
applications including bone tissue engineering. However, this group of materials is not
considered in this dissertation where the focus is on biocomposites and bioceramics. It will
be also shown that the bioceramic component incorporated into the biopolymer fibers
enhances both cell responses and mechanical performance compared to the bare biopolymer
fibers.
4.3.1 Electrospun crystalline bioceramic fibers
Only a very limited variety of bioceramic materials has been studied for bone scaffold
applications. The major limitation of electrospun crystalline ceramic nanofibers is their
inherent brittleness that prevents their usage as such in load bearing applications. If
crystalline ceramic fiber scaffolds were to be used in these applications, they would need to
be incorporated in an additional biocompatible framework with better mechanical
properties. Another prospect is to use the fibers as bioactive fibrous coatings on implant
surfaces for faster integration with the native tissue.105 Even though ceramic fibers are
mechanically restricted, there are still several studies about their preparation and
biocompatibility.
TiO2 is widely known as a highly biocompatible material and several electrospinning
processes have been reported for it although in most studies the focus has been outside
biomedical applications.106 The anatase phase of TiO2 has been found out to be beneficial
for bioactivity by comparing SBF and cell culture performance of electrospun fibers
annealed at 450, 600 and 900 °C resulting in brookite/anatase, brookite/anatase/rutile and
brookite/rutile fibers, respectively.105 In the cell culture studies 600 °C was found to be the
optimal calcination temperature, attributed to the brookite/anatase being favorable phase
composition as compared to brookite/anatase/rutile mixture. However, between 450 and
600 °C the difference could also be driven by increased crystallinity in the fibers annealed
at higher temperature whereas the absence of anatase at 900 °C was clearly unfavorable for
bioactivity. Effect of fiber structure, i.e. bead density and fiber diameter were hard to detect
in SBF studies, but cell cultures showed clearly better performance for uniform fibers
compared to beaded fibers. Other studies have also shown that the cell response can be tuned
by structural parameters. Wang et al.107 compared different fiber diameters with or without
additional microroughness produced by patterned collector meshes and showed that both
micro- and nanotopography could be used to tune the response in the various stages of
osteoblast proliferation and maturation.
Calcium phosphates are a widely used class of bioceramics for bone scaffolds and bioactive
coatings. Hydroxyapatite as the ceramic component in native bone is among the most used
and interesting bioceramic materials. Electrospinning studies on calcium phosphates have
thus far been focused on hydroxyapatite with no reports on other calcium phosphates. A few
different processes have been reported for fabrication of hydroxyapatite fibers via
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electrospinning (Table 3).108-116 Most studies rely on Ca(NO3)2 as the calcium precursor
whereas P2O5, triethyl phosphate (TEPO), triethyl phosphite (TEP) and diammonium
phosphate (DAP) have been studied as the phosphorous precursor. Also calcium deficient
HA nanoparticles have been spun with PLGA and sintered at 1100 °C in argon to form
continuous HA fibers.115 Electrospun HA fibers are typically accompanied with impurity
phases of β-TCP, CaO and/or CaCO3 depending on the annealing temperature and
precursors used. The first report on electrospinning of hydroxyapatite successfully
demonstrated phase pure hydroxyapatite after annealing electrospun CaNO3/triethyl
phosphate/PVP fibers at 600 °C.108 However, the quality of the fibers was quite poor with
an exceptionally large average fiber diameter over 10 μm. In other studies much smaller
fiber diameters have been achieved with the smallest reported exact values being at 122±32
nm.111 Kim and Kim prepared fluorohydroxyapatite nanofibers by using NH4F in the
solution to partially substitute the OH- groups in HA with F-.109 The fluorinated fibers could
have applications in dental restoration, but only the preparation and characterization of the
fibers was reported by the authors. Mesoporous Eu3+ doped HA fibers were studied as drug
carriers with photoluminescence properties dependent on drug loading.110 Although the
drug loading studies were performed in SBF, no bone forming ability tests or cell culture
studies were conducted.
Table 3. Hydroxyapatite electrospinning processes found in literature.
# CaCO3 not reported in the text, but can be detected from the calcite (104) peak at 29.4° in the XRD data.
¤ CaO not reported in the text, but visible from the calcia (200) reflection at 37.3° in XRD data.
† Also Ca10(PO4)6(OH, F)2 fibers when NH4F was added into the electrospinning solution.
* 5 mol% Eu3+ was incorporated in the HA lattice.
Previously unmentioned abbreviations found in the table: TFE=2,2,2-trifluoroethanol, HFIP=1,1,1,3,3,3-
hexafluoroisopropanol.
Ca prec. P
prec.
Polymer Solvents Annealing
(in air)
Smallest avg.
fiber diameter
Impurity
phases
Ref
Ca(NO3)2 TEP PVB H2O, EtOH 700 °C 236 nm
CaCO3#,
CaO¤
109†
Ca(NO3)2 · 4H2O TEP PVA H2O 600 °C ~200 nm CaO, β-TCP
112-
114
Ca(NO3)2 · 4H2O TEP Gelatin H2O,EtOH, TFE
600 and
800 °C
400±52 nm CaO¤ 116
Ca(NO3)2 · 4H2O TEPO PVP 2-ME, H2O 600 °C ~10-30 μm - 108
Ca(NO3)2 · 4H2O TEPO PVP 2-ME, H2O 800 °C ~500 nm CaCO3, CaO III, V
Ca(NO3)2 · 4H2O  P2O5 PVP H2O, EtOH
600 and
700 °C
122±32 nm
β-TCP, CaO,
CaCO3#
111
Ca(NO3)2 · 4H2O DAP PVP
H2O, EtOH,
HNO3, citric acid
500-800 °C ~75-150 nm - 110*
Ca-deficient HA particles PLGA HFIP
1100 °C in
argon
~1 μm β-TCP 115
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In fact very little is known about the biomedical properties of electrospun HA fibers. Lee
and Kim reported the only study on HA fiber performance in SBF, which showed good bone
forming ability as the fibers were fully covered by flake-like apatite after 12 h in solution
and the pores of the fiber sheet were filled by the apatite formed after 3 days of immersion.116
Cell viability assay with mouse calvaria osteoblast precursor cells (MC3T3-E1 cells)
showed that these cells were able to attach, spread and proliferate faster on the fiber
membrane compared to the tissue culture plate control (Figure 8) and in fact the fiber
scaffolds were fully covered by the cells after 5 days of culture. The only other
biocompatibility studies on electrospun HA include the cytotoxicity examination and human
osteoclast cell cultures on HA fiber scaffolds presented in the results section.III
Cell viability of MC3T3-E1 cells incubated on electrospun hydroxyapatite
fiber membrane calcined at 800 °C. TCP = tissue culture plate used as control. Reprinted
from [116] with permission from Elsevier, Copyright (2014).
4.3.2 Electrospun bioactive glass fibers
As compared to the crystalline bioceramics, glass fibers as amorphous materials are less
fragile and thus more suitable for load bearing scaffolds from the mechanical perspective.
In the family of different bioactive glasses several electrospinning studies have focused on
the SiO2-CaO-P2O5 glasses.117-122 Although the compositions reported in literature vary
somewhat, the precursor selection has been is quite narrow with tetraethoxysilane (TEOS),
Ca(NO3)2 and TEPO extensively used for SiO2,  CaO  and  P2O5 respectively. Somewhat
surprisingly the first and most well-known bioactive glass composition, the Bioglass 45S5
(46.1 mol% SiO2, 26.9 mol% CaO, 24.4 mol% Na2O and 2.6 mol% P2O5) had not been
electrospun until very recently.123, 124 Either NaCl or NaNO3 were used as the Na precursor.
However, in both studies partially crystalline fibers were obtained instead of a single glassy
phase. Other compositions studied include SiO2-CaO, SiO2-B2O3-CaO-P2O5, SiO2-CaO-
K2O-Na2O-MgO-P2O5 and SiO2-CaO-P2O5-MgO classes of materials.125-129 Tributyl borate
was used as the boron precursor in the only report about electrospinning of borosilicate glass
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fibers.125 Bioactive glass fibers can be doped with trace elements such as gallium and cerium
for antibacterial or other therapeutic effects.129 Calcination temperatures to remove the
carrier polymers and form the glassy phase and typically vary between 500-700 °C.
Unlike hydroxyapatite fibers, different bioactive glass fibers have been well studied in
respect of their bioactive properties for bone tissue engineering. SBF studies have shown
bone forming ability with full HCA coverage typically forming within 3 days in solution
(Table 4). Multiple studies have evaluated in vitro cell culture performance, typically with
pre-osteoblastic mouse MC3T3-E1 or human osteosarcoma MG-63 cells. There are some
variations in both the SBF and cell culture results presented in separate studies even for
fibers of the same composition.117, 118 This can be attributed to variations in other
contributing factors such as fiber diameter, surface area and porosity. Thus it is hard to
detect clear differences in bone forming ability or cell culture performance that could be
attributed solely to the compositional differences in fibers. Bioactive glass SiO2-CaO-P2O5
70-25-5 has been shown to have better cell viability and alkaline phosphatase (ALP)
production compared to similarly structured PCL biopolymer nanofibers, which highlights
the significance of the bioceramic component for the cell interactions.117 Likewise the
fibrous structure contributes as a dense bioactive glass is performing worse compared to the
electrospun nanofibers of same the composition. It has been demonstrated that mesoporosity
of bioactive glass fiber surfaces improves their HCA forming ability in SBF and also cell
viability.120, 122 One reason is most likely the increased surface area of the fibers which leads
to faster dissolution. Surfactants such as N-cetyltrimethylammonium bromide (CTAB),
Pluronic P123 and Pluronic F127 can be added to the electrospinning solution to achieve
controlled surface porosity.120, 125, 130
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Table 4. Some SBF studies on electrospun bioactive glass fibers with different
compositions and fiber morphologies.
Fiber composition Fiber morphology _SBF study (HCA formation) Ref
SiO2-CaO-P2O5
 58-38-4 Smooth 3 days: fibers covered with HCA 121
 70-25-5 Smooth 6h: HCA particles; 12h cauliflower-like
structures; 24h: full HCA coverage
118
 70-25-5 Smooth 1 day: some elongated HCA crystals; 3 days:
surface almost fully covered by the crystals
117
 70-25-5 (in wt. %) Mesoporous and
hollow
8h: Spherical particles; 24h: HCA nanorods
all along the surface
122
 107-69-5 Fibers and tubes (Co-
axial electrospinning)
1 day: partial coverage; 3 days full HCA
coverage, in tubes HCA crystals form also
inside the tube
119
 78.8-14.4-3.4 Smooth 1.5x concentrated SBF study: 1 day: some
particles; 14 days: partial coverage
120
SiO2-CaO-P2O5-MgO
 29.4-37.14-32.06-
1.66 (in wt. %)
Smooth 6h: almost no HCA crystal formation; 12 h
partial HCA layer formed
127
SiO2-CaO-Na2O-P2O5
 46.1-26.9-24.4-2.6
(Bioglass 45S5)
Smooth 1 day: surface covered with HCA layer 124
 46.1-26.9-24.4-2.6
(Bioglass 45S5)
Hollow 3 days: some elongated HCA crystals 123
SiO2-CaO-K2O-Na2O-MgO-P2O5
 53-20-12-6-5-4
(13-93 glass)
Smooth 1 day: some particles; 5 &7 days: partial
coverage; 30 days: full HCA coverage
128
 53-20-12-6-5-4
+ (0-5 wt. %) Ga2O3
Smooth Reduced HCA formation with increasing
doping concentration
129
 53-20-12-6-5-4
+ (0-5 wt. %) Ce2O3
Smooth Reduced HCA formation with increasing
doping concentration
129
SiO2-B2O3-CaO-P2O5
 47-23-25-5 Smooth-mesoporous 1 day: partial HCA coverage; 3 days: surface
almost fully covered by the crystals; 5 day:
full coverage (mesoporous fibers)
125
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4.3.3 Electrospun biocomposite fibers
Particle loading of electrospun biopolymers
In the area of biocomposite fibers there are numerous alternatives that can be studied for
bone scaffolds.17 Not only are there various possibilities to choose one or multiple
biopolymer and bioceramic components, but also the ratio of these affects both the
mechanical and biological properties. Electrospinning of biocomposites is most often
performed from a mixture of dissolved polymer and bioceramic nanoparticles. Some
common polymers studied include the natural biopolymers collagen (Col), chitosan (CTS),
gelatin (Gel) and silk fibroin. Synthetic polyesters PCL, PLA [poly-L-lactic acid (PLLA),
poly-D-lactic acid (PDLA) or poly-D,L-lactic acid (PDLLA)] and PLGA are also
commonly explored. Multiple electrospinning processes for all these biopolymers are
readily available. CTS is somewhat difficult to electrospin and thus usually needs to be
mixed with small amount of another more electrospinnable polymer.131-133 Generally the
synthetic polyesters tend to have better mechanical properties compared to the natural
biopolymers. However, although considered biocompatible, the degradation of these
polyesters can result in generation of a local acidic environment within the body and
consequent adverse effects.134 Collagen as a natural component of bone can be considered
ideal in respect of the biocompatibility and degradation, but is limited in mechanical
properties and cost.135
Several publications have reported that HA nanoparticle addition into a biopolymer fiber
matrix, such as PLA, PCL, PLGA, CTS, Gel or Col, leads to enhanced biological
properties.132, 136-146 For example, many studies have shown PLA/hydroxyapatite composite
fibers to have enhanced cell viability, attachment, proliferation and cell differentiation into
osteoblast compared to the bare electrospun PLA.138-144 Other bioceramics combined with
different biopolymers include β-TCP, CaCO3 and bioactive glasses.147-153 Deng and
coworkers reported enhanced cell attachment, spreading, proliferation and differentiation in
vitro for β-TCP/Gel fibers with increasing β-TCP content up to 20 wt.%.149 Notably the
applicability of their 20 wt. % β-TCP/Gel fibrous scaffold was later verified also in vivo as
the scaffold was shown to significantly enhance the rate of new bone formation in rabbit
mandible (jaw) bone defects.150 Prabhakaran et al.154 compared the cell culture performance
of 20/40/40 HA/Col/PLLA and 20/80 HA/PLLA fibers and found out that the partial
collagen substitution enhanced osteoblast adhesion and growth on the fiber membrane.
Comparable results were reported when CTS or PCL instead of PLLA was partially
substituted with Col.132, 155 Similarly HA/PCL/Gel composite fibers were shown to have
higher cell proliferation and ALP activity compared to HA/PCL and HA/Gel fibers.135 Still,
in all these studies a decrease in tensile strength was also observed with increasing Col or
Gel content.
The mechanical properties of biocomposite fibers depend on multiple factors including the
biopolymer, bioceramic, fiber diameter, porosity, and the particle content, size, and
especially particle distribution. Nanoparticle addition into the polymer matrix can lead to an
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increase in tensile strength and Young’s modulus.143-146, 156-159 Tensile strengths reported in
literature for electrospun biocomposites typically vary in the range of 2-6 MPa and the
Young’s moduli from about 1 to 400 MPa depending mostly on the polymer and particle
concentration and distribution.145, 146, 157-159 Commonly an initial increase in tensile strength
and modulus is seen with increasing concentration of the stiff particles into the polymer
matrix, but after a critical concentration is reached the particles disrupt the polymer chain
entanglements and result in brittleness. Homogeneous distribution of particles along the
fibers is crucial for maximizing the tensile strength and modulus of the composite fibers.
Electrospinning of a suspension of nanoparticles in a polymer solution easily leads to a
formation of particle agglomerates within the fibers and the effect is more substantial the
higher the particle concentration in the initial suspension. Particle distribution can be
improved by the addition of coupling agents and surfactants, by using polymer-grafted
particles and also by in situ particle synthesis in the electrospinning solution.136, 138, 145, 146,
157, 158 For example, Li et al.136 saw γ-glycidoxypropyltrimethoxysilane (also known as
A187) surface modification of HA particles to significantly enhance the particle distribution
in 30 wt. % HA/PCL composite fibers and consequently lead to increased tensile strength
and Young’s modulus compared to the bare PCL and unmodified HA/PLA composite fibers
(Figure 9). In HA/silk fibroin fibers with the A187 modified HA particle content between
0-40 wt. %., the maximum tensile strength of ~3.1 MPa and modulus of 150 MPa were
achieved at a HA concentration of 20 wt. %.157 Xu et al.158 reported an increase in tensile
strength and modulus for fibers with up to 4 wt. % of PLA grafted HA particles incorporated
in an electrospun PLA fiber matrix. In contrast, using non-grafted HA particles the tensile
strength was gradually decreasing with increasing HA content up to the maximum reported
content of 30 wt. % and modulus started decreasing already after 2 wt. % concentration.
TEM images of electrospun PCL, unmodified HA/PCL and (A187 modified
HA)/PCL fibers and the stress-strain curves of the respective scaffolds. Reprinted from
[136] with permission of Springer, Copyright (2011).
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Mechanical properties can be further improved by cross-linking of the composite fiber
network after electrospinning with solution or plasma treatment. A very high tensile strength
of 5.2±1.7 MPa and Young’s modulus of 326±88 MPa could be achieved for 20 wt. %
HA/Gel fibers by combining biomimetic co-precipitation prior to electrospinning with post-
electrospinning solution cross-linking.146 The HA content of 20 wt. % was found optimal as
fiber membranes with 0 and 40 wt. % HA had both lower tensile strength and ALP activity.
Coating of electrospun biopolymers
As the interaction with cells occurs on the fiber surfaces, multiple studies have examined
the coating of biopolymer fibers with a bioceramic coating to maximize the interaction of
the bioceramic component with cells while preserving the mechanical properties of the
biopolymer fiber matrix. Several publications have depicted the use of simulated body fluid
(SBF) to deposit a HCA layer on different biopolymers. Especially on hydrophobic
biopolymers, e.g. polyesters, the process can be very time consuming with several days or
even weeks required to obtain a continuous coating,160 but the rate can be improved by using
a concentrated SBF and/or surface activation of the polymer surfaces.161-165 Surface
activation is typically done by treating the electrospun samples either with a basic solution
or plasma resulting in an increased concentration of hydrophilic groups on the surface.
Significantly enhanced apatite formation rate in SBF was also achieved by hydroxyapatite
seed crystals formed on electrospun PCL fibers by sequential dipping in calcium and
phosphate ions containing solutions.166 HCA coated polymer fibers have been reported to
have increased cell viability, proliferation and differentiation compared to the bare
biopolymer fibers.163, 166
Surface activated polyester fibers can also be nanoparticle-coated by ultrasonication in a
nanoparticle suspension.167-169 Coating of electrospun PLLA and PLLA/HA fibers with HA
nanoparticles by this method was shown to result in very homogenous particle coverage
along the fiber surfaces and the coated fiber membranes were shown to promote new bone
formation in vivo compared to the non-coated counterparts.169 Simple dipping in HA
nanoparticle suspension for overnight has been shown to result in a nanoparticle coating on
the surfaces of plasma treated PLLA fibers, though compared to the ultrasonication method
the particle distributions were less homogeneous.170, 171 In vivo studies with the PLLA fibers
coated with HA, Bioglass (BG) 63S (63 mol % SiO2, 28 mol % CaO, and 9 mol % P2O5),
HA and BG, or TCP nanoparticles revealed that the new bone formation rate increased in
the order: no coating<HA<BG<TCP<BG-HA. Nanoparticles can be deposited on fiber
surfaces also in situ via simultaneous electrospinning and electrospraying of biopolymer
and bioceramic, respectively.172-175 The electrosprayed hydroxyapatite particles on the fiber
surfaces enhance the cell responses compared to fibers with the particles embedded in the
biopolymer matrix, but the fiber membranes with embedded particles tend to have higher
tensile strength and modulus.
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4.3.4 Solution blown and electroblown bioceramics and composites
As SBS and EB are relatively new methods there are thus far only very few studies on
preparation of inorganics or composites for bone scaffolds. Compared to the electrospun
fiber morphology the solution blown fiber membranes contain more beads and fused fibers.
Common biopolymers of PLA,86, 88-90, 176, 177 PLGA92 and PCL89 have been solution blown,
but reports on SBS of biocomposites are scarce. Zirconium substituted amorphous calcium
phosphate has been combined with PDLLA and PCL.178 Hydroxyapatite nanoparticles have
been solution blown with PLA94 and  PVAc95, and electroblown with poly(3-
hydroxybutyrate)179. The HA/PLA fibers enhanced cell proliferation and differentiation and
additionally a very high tensile strength of 34±1 MPa was reported. However, further studies
are required on the mechanical properties as commonly solution blow spinning results in
lower tensile strength compared to the electrospun fibers.89
Ceramic TiO2 fibers were prepared by SBS of titanium isopropoxide/PVAc followed by
annealing at 500 °C, but no biological studies were performed.95 The fiber morphology
could be tuned by the ratio of PVAc and Ti(OiPr)4 in the spinning solution from smooth
[25 % Ti(OiPr)4] to tubular [35 and 50 % Ti(OiPr)4]. Somewhat surprisingly bioactive glass
fibers were prepared by solution blow spinning of a SiO2-CaO-P2O5 sol without any
polymer additive already in 2001, though a term ‘High velocity spray process’ was used.180
Like their electrospun counterparts, solution blown bioactive glass microfibers in the SiO2-
CaO-P2O5 family have been determined to be bioactive in SBF.180-182 However, the SiO2-
CaO-P2O5 fibers that were solution blown from a SiO2-CaO-P2O5 sol without any polymer
additive produced only a very thin layer of individual HCA crystals on the fiber surfaces
even after 15 days of SBF immersion and demonstrated reduced cell viability compared to
bulk glasses and control samples.180, 181 In contrast, SiO2-CaO-P2O5 bioactive glass fibers
formed by calcination of the polymer containing solution blown composite fibers at 700 °C
rapidly formed a fully continuous HCA layer around the fibers after 24 h in SBF and the
layer continued to thicken upon further immersion.182 Comparing the results the annealing
step at 700 °C seems to be contributing to the bioactivity as the membranes spun from the
SiO2-CaO-P2O5 sol were only dried at low temperatures after being blown into fibers. For
the annealed fibers, the composition SiO2-CaO-P2O5=80-15-5 was reported to have higher
bioactivity compared to the ratio 75-25-5.182 Preliminary cell culture studies on the SiO2-
CaO-P2O5=80-15-5 fibers exhibited no cytotoxicity, and good cell attachment and
spreading.
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4.3.5 Tailoring the structure of nanofiber networks
As discussed in the previous sections, various bioceramic and biocomposite fibers provide
a favorable microenvironment for cell attachment, proliferation and differentiation upon
implantation and are capable of bonding with bone tissue. However, the pore size in
electrospun fiber networks is usually insufficient for effective cell infiltration within the
scaffold. 183, 184 It should be noted that the accurate measurement of pore sizes is difficult
due to the open three-dimensional fiber network structure. In literature pore sizes are usually
evaluated via SEM or by porosimetry. For electrospun fibers with diameters of 100-500 nm
the pore size is typically around 1-10 μm and thus too small for cell infiltration.184 Increasing
the fiber diameter results in larger pores, but reduces the overall surface area. Solution
blown fiber samples tend to be accompanied with larger pores due to fiber bundling and
therefore provide a more suitable environment for the cell penetration.89 Especially in the
case of crystalline bioceramics, the brittleness of the fibers can limit their usability.
Therefore there are needs to develop methods for modifying the as-prepared fiber networks
to introduce additional porosity and/or to enhance the mechanical properties via addition of
strengthening components.
Additional overall porosity can be introduced during the electrospinning process by
modified collectors e.g. by liquid collector systems or electric field guiding collectors that
direct the as-spun fibers into a more porous three dimensional shape compared to
conventional planar target.185-187 Cooled collectors can be used to form ice crystals on the
fiber membranes; the ice crystals are incorporated into the fiber matrix during
electrospinning and subsequently removed after the deposition.188-190 Pore  size  can  be
increased similarly by incorporating salt crystals or co-electrospun sacrificial polymers into
the fiber mesh during the process and selectively removing the additives.191-193 Pores can be
also made into the structure after the deposition, e.g. mechanically or by lasers. Sharp
needles have been used to puncture controlled pore arrays through electrospun fiber
membrane structures.194 Electrospun 15 wt. % β-TCP/PCL composites, with arrays of
418±51 μm pores made by pulse Ti:sapphire laser, showed significantly enhanced cell
proliferation and calcium mineralization compared to scaffolds with comparable
macropores made by 3D-printing (Figure 10).195 Although the methods to increase pore size
are generally applied on polymer or biocomposite fiber meshes, they could also be used to
introduce pores into bioceramic fiber membranes, because when applied the on as-spun
fibers, the produced porous shape could be preserved during the calcination. However, the
calcination process would need to be carefully optimized to preserve the shape and to take
into account the shrinkage occurring during the calcination of the as-spun fibers.
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(a)–(b) Optical and (c)–(e) SEM images of electrospun 15 wt. % β-TCP/PCL
biocomposite scaffolds with pores mady by laser-processing. The cellular morphology of
proliferated MG-63 cells after culturing for 14 days (e) on the electrospun scaffold and on
(f) a 3D-printed scaffold with comparable macropores. The insets show the fluorescence
images describing the nucleus (blue) and F-actin (red) on the scaffolds. Optical micrographs
of alizarin red S staining indicating calcium mineralisation on (g) the electrospun scaffold
and on (h) the 3D-printed scaffold. Reprinted from [195] with permission from Elsevier,
Copyright (2014)
Electrospun fibers can also be assembled into rods or filaments that can be used as building
blocks for three-dimensional filament scaffolds.196 This approach has been used to prepare
three-dimensionally crafted bioactive glass fibers. The as-spun composite fibers could be
assembled as sheets, rods, and three-dimensional macrostructures and the structures were
preserved in the calcination process (Figure 11a-c).117 An interesting prospect for preparing
biocomposites is to use bioceramic fibers combined with biopolymers to produce composite
materials that consists of continuous nanofibers and a biopolymer filler (Figure 11d).117
Amorphous bioactive glass fibers can be more easily used in this method as their durability
is higher compared to the very brittle crystalline bioceramic fibers. This approach has been
used to produce dense sheets of PLA and bioactive glass fibers by infiltration of
PLA/tetrahydrofuran solution into the fiber membrane and followed by vacuum drying and
thermal pressing.121 Porous Col/bioactive glass fibers composite scaffolds have been made
by freeze-drying a mixture of SiO2-CaO-P2O5 fibers in Col/water solution.197 In both cases
the bioactivity and cellular response improved compared to the pure PLA and Col without
the nanofiber additives. Composites of PCL and bioactive glass fibers showed improved
bone formation compared to bare PCL also in vivo, though the fibers were used purely as
nanofiller rather than as a continuous electrospun fibrous structure.198
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Examples of three-dimensional macrostructures of electrospun bioactive glass
SiO2-CaO-P2O5=70:25:5. a) Filament: electrospun nanofibers aligned and bundled into a
microfilament. b) Membrane: electrospun sheets stacked. c) three-dimensional macroporous
scaffold made from the filaments d) Polymer-filled nanocomposite: heat-treated fibrous
mesh filled with PLA. Reprinted from [117] with permission from John Wiley and Sons,
Copyright (2006).
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5 Experimental
5.1 Fiber preparation
Conventional single needle electrospinning setup was used for the fiber preparation in
publications II,III and VI. A syringe pump was used to control the feed rate of solution
through a metallic 22 or 27 G blunt needle spinneret that was set to a high voltage with a
high voltage power source. The ejected fibers were collected on a grounded silicon wafer
or a rotating collector.
EB and SBS experiments were performed with a self-built spinneret where a gas delivery
system was attached to the standard electrospinning setup (Figure 12). The spinneret
consisted of a 2.5 mm metal nozzle at the center of which the 27 G needle was placed
protruding ~1 mm. The fibers were collected on a cylindrical metal grid collector with a
stationary planar metal grid as the back collector.
Publication V describes a new kind of needleless electrospinning tool (Needleless twisted
wire electrospinning, NTWE) where, instead of a needle, a metallic twisted wire is used as
the spinneret (Figure 12). The electrospinning solution was delivered from the syringe pump
on top of the vertically oriented twisted wire via a silicone tubing. From the top of the
twisted wire the solution enters a rotational downward gravitational flow. The solution is
set to a high voltage with the high voltage power source, which causes multiple Taylor cones
to form on the surface of the downward flowing solution on the wire. The erupted polymer
jets are then collected as nanofibers on a grounded cylindrical collector around the wire.
The schematic diagrams of the EB and needleless twisted wire electospinning
setups. The inset shows a picture of the EB nozzle.
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The chemicals used in fiber preparation are collected in Table 5. The solution combinations
used to prepare the fiber materials in this study are presented in Table 6. In the preparation
of inorganic fibers the as spun fibers were calcined in an air furnace to reach the target
material. Further details about the experimental parameters used can be found in the
respective publications.
Table 5. Chemicals used in the electrospinning and electroblowing solutions.
Chemical name Abbreviation Chemical formula Quality Manufacturer
Polymers
 Polyvinyl pyrrolidone PVP
N O
n
Mw = 1 300 000 Alfa Aesar
Polylactic acid PLA O
O
CH3
n
IngeoTM 6201D
Fiber Grade
NatureWorks
Other precursors
Calcium(II)nitrate
tetrahydrate
- Ca(NO3)2·4H2O 99 % Riedel-de Haën
 Triethyl phosphate TEP (C2H5O)3PO 99 % ABCR
 Tetraethoxysilane TEOS Si(OC2H5)4 98 % Aldrich
Hydroxyapatite
nanoparticles
nHA Ca5(PO4)3OH 97 %, ≤200 nm Aldrich
Solvents
 Ethanol EtOH CH3CH2OH
 2-methoxyethanol 2-ME CH3OCH2CH2OH
 Deionized water H2O
 Chloroform - CHCl3
 N,N-dimethylformamide DMF HCON(CH3)2
Table 6. Electrospinning and electroblowing solutions and the calcination temperatures of
the as-spun fibers for each material.
Target material Polymer Other precursors Solvents Calcination Ref.
PLA PLA - CHCl3 and DMF - VI
nHA/PLA* PLA nHA CHCl3 and DMF - VI
PVP PVP - EtOH - V
CaCO3 PVP Ca(NO3)2·4H2O EtOH or 2-ME 500 °C II
Hydroxyapatite PVP Ca(NO3)2·4H2O, TEP 2-ME 800 °C III, V
Hydroxyapatite PVP Ca(NO3)2·4H2O, TEP EtOH and H2O 800 °C IV
Bioactive glass# PVP Ca(NO3)2·4H2O, TEP, TEOS  2-ME 700 °C V
*nHA/PLA = 20/80 and 50/50 (weight ratio), #SiO2:CaO:P2O5 = 70:25:5 (molar ratio).
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5.2 Film depositions
Spin and dip coating was used in the preparation of fibrous CaCO3 coatings to improve the
adhesion of the fibers to the substrate. Spin coatings were performed on annealed CaCO3
fibers on silicon with a Speedline technologies P6204 spin coater at a rotating speed of
4000 rpm for two minutes. A precursor solution with 0.15 g of Ca(NO3)2∙4H2O dissolved
in 6 ml of 7 wt. % PVP/2-ME was used and 0.2 ml of that solution was used in each coating.
Dip coated films were prepared with a KSV Instruments DXS2 dip coater using a solution
where 1.0 g of Ca(NO3)2∙4H2O had been dissolved into 40 ml of 7 wt. % PVP/EtOH. The
CaCO3 fibers on silicon were dipped into the solution once and lifted up with a speed of
3 cm/min. After spinning or dipping the coated fibers were annealed at 500 °C in air for 2 h
using a heating rate of 1 °C/min.
ALD CaCO3 thin films were deposited via the Ca(thd)2-O3 process.199 The experiments were
carried out in a F120 (ASM Microchemistry Ltd.) ALD reactor on 5x5 cm2 silicon (100)
and unpolished titanium substrates. The reactor was operated under nitrogen atmosphere at
a low pressure of about 5–10 mbar. The precursors were sequentially pulsed into the reaction
chamber separated by inert gas purges. N2 was used as the carrier and purging gas and 1s
precursor pulses and purges were used in all experiments. Ca(thd)2 (Volatec Oy) was
evaporated from an open source boat at 188 °C and O3 was generated from O2 (99.9999%)
with an ozone generator (Wedeco, Ozomatic Modular 4 HC Lab).
5.3 Conversion of CaCO3 to hydroxyapatite
CaCO3 fibers and coatings were converted to nanocrystalline hydroxyapatite by wet
treatment in a diammonium hydrogen phosphate [(NH4)2HPO4, DAP] solution. Prior to the
treatment both the solution and the sample were preheated to the target temperature in an
air oven. Conversions were carried out for 1-60 min at RT, 80 or 95 °C. After the conversion
the samples were rinsed with deionized water and dried.
5.4 Characterizations
A Hitachi S-4800 field emission scanning electron microscope (FESEM) was used for
imaging of the samples. Sputtered Au/Pd was used to improve the image quality if
necessary. Fiber diameters were analyzed with ImageJ software from the FESEM images.
Thermogravimetric analyses (TGA) were done with a Mettler Toledo Stare system equipped
with a TGA 850 thermobalance. Fourier transform infrared spectra (FTIR) were recorded
with a Bruker Alpha-P spectrometer. A PANalytical X’Pert Pro MPD X-ray diffractometer
using CuKα-radiation was used for X-ray diffraction (XRD) studies. The diffractometer was
attached with an Anton-Paar HTK1200N oven for high temperature X-ray diffraction
(HTXRD) measurements. ALD film thicknesses and refractive indices were determined
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from reflectance spectra measured at 370-1100 nm by a Hitachi U-2000 spectrophotometer.
Adhesion studies were conducted by the common Scotch tape test.
Characterizations performed by collaborators include time-of-flight elastic recoil detection
analysis (ToF-ERDA) of thin film coatings and measurements of the mechanical properties
and porosity of electrospun fiber sheets. ToF-ERDA was used to study the elementary
concentration depth profiles of hydroxyapatite films at the Materials Physics Division at
University of Helsinki. The ultimate tensile strength, Young’s modulus and elongation at
break of the electrospun PLA and PLA-HA fiber sheets were evaluated at room temperature
using a Zwick/Roell Z2.5 tensile testing machine at the Institute on Membrane Technology
at National Research Council of Italy (ITM-CNR). The porosity of PLA and PLA-HA fiber
sheets was evaluated by comparing bulk densities and fiber sheet densities obtained from
weight and volume measurements.
5.5 Biological studies
Various studies to determine the biocompatibility and bioactivity of the prepared materials
were performed by collaborators at the Department of Anatomy and Cell Biology at
University of Oulu and Institute on Membrane Technology at Italian National Research
Council (ITM-CNR). The detailed experimental procedure of those studies can be found in
the respective publications. In addition SBF immersion studies were performed according
to literature30 by the author. All the biological studies are collected in Table 7.
Table 7.  Biological studies performed on the prepared materials.
Study Time period Ref.
Simulated body fluid immersion study 7 days IV
Dissolution in cell culture medium 12 days I
Cell culture with human primary osteoclasts 12 days I, III
Cell culture with mouse macrophage cell line 4 days III
Cell culture with human mesenchymal stem cells (hMSCs): differentiation of the
cells into osteoblasts
46 days VI
Cell culture with human promyelomonocytic leukemic U-937: differentiation of
the cells into osteoclasts
26 days VI
Co-culture of hMSCs and U-937: hMSCs differentiated into osteoblasts for 20 days
followed by addition of U-937 cells and co-culture for 26 days (see Figure 14).
46 days VI
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6 Results and discussion
6.1 Electrospun polylactic acid and polylactic acid-hydroxyapatite
fibers
PLA fibers were electrospun from solutions made by dissolving PLA in CHCl3 and DMF.VI
Hydroxyapatite nanoparticles were mixed to the solution for electrospinning of nHA/PLA
fibers with 20 and 50 wt. % nHA. TGA verified that the nHA content in the electrospinning
mixtures was carried out into the respective composite fibers with 20.0 and 49.3 wt. %
weight residue after PLA decomposition. FTIR of the PLA and nHA/PLA fibers showed
the expected characteristic peaks of each material. FESEM images of the PLA and
composite nHA/PLA fibers are presented in Figure 13. Due to the nanoparticles, the
composite fibers are coarser compared to the PLA fibers. Still, regardless of the PLA content
the surface of the fibers was porous most likely due to the combined humidity and phase
separation effects during the electrospinning process. The nanoparticles are seen dispersed
along the outer surface and pores with some aggregates of multiple particles, especially on
the fibers with 50 wt. % nHA. Thus there is both HA and PLA available to interact with
cells. The fiber diameter also increases with increasing nHA content. The fiber diameters
along with the measured mechanical properties of the fiber scaffolds are collected in Table
8.
Electrospun (A) PLA and nHA/PLA with (B, D) 20 and (C) 50 wt. % nHA.
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Table 8.  Average fiber diameters and mechanical properties of electrospun PLA and PLA-
nHA fiber scaffolds.
PLA 20 wt. % nHA/PLA 50 wt. % nHA/PLA
Fiber diameter (nm) 770 ± 350 840 ± 330 1030 ± 390
Porosity (%) 80 ± 3 91 ± 2 70 ± 4
Elastic modulus (MPa) 14.25 ±1.35 10.48 ± 0.69 4.10 ± 1.75
Tensile strength (MPa) 0.84 ± 0.07 0.98 ± 0.13 0.23 ± 0.07
Elongation at break (%) 48.81 ± 6.20 48.55 ± 4.70 37.23 ± 8.22
The prepared fiber scaffolds were subjected to cell culture studies according to the
paradigms presented in the experimental section (Table 7) and Figure 14.VI The cell
viability, ALP, cathepsin K and TRAP activity results from the studies are collected in
Figure 15. In the homotypic cultures the hMSCs adhered and proliferated on all the scaffolds
followed by differentiation into osteoblasts. This was evident for example by the expression
of osteoblast specific markers osteopontin, osteocalcin, and evaluation of alkaline
phosphatase (ALP) activity. Likewise the homotypic culture of U-937 cells led to
aggregation and attachment of the monocytes into multinucleated cells and differentiation
into osteoclasts as verified by multiple tests e.g. by detection of osteoclastogenic molecules
cathepsin K and tartrate-resistant acid phosphatase (TRAP).
The co-culture study was conducted as presented in Figure 14.VI First only the hMSCs were
added into the scaffolds (day 0-0) and cultured for 20 days (day 20-0). At this point the U-
937 cells were added into the scaffolds (day 20-0) and co-cultured for 26 more days (day
46-26). The first number in parenthesis thus indicates the number of days cultured with
hMSCs and the second number the days co-cultured with U-937 cells. In this study increased
cell viability was noticed for all scaffolds compared to homotypic cultures (Figure 15). The
presence of nHA improved cell viability especially in scaffolds with 20 wt. % nHA. Similar
phenomena was observed in osteogenic and osteoclastogenic differentiation. The expression
of ALP and TRAP activity as well as cathepsin K secretion were higher in the co-cultured
scaffolds and in the scaffolds with nHA, especially in the scaffolds with 20 wt. % nHA. It
seems the co-cultured cells are cross talking and cooperating during the culture and thus the
composite scaffolds seem to provide a suitable microenvironment for to be incorporated in
the natural remodeling process of bone.
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The experimental procedure of the co-culture study performed in Pub. VI.
 (A) Cell viability of osteoblasts (OSB) and osteoclasts (OSC) in homotypic and
in co-culture system on the scaffolds after 46–26 days of culture. (*) vs PLA and PLA–
nHA-50 fiber scaffolds for each cell type; (‡) vs PLA scaffolds for each cell type. (B) ALP
secreted by osteoblasts in homotypic and in co-culture system. For each cell culture
condition during the culture time: (*) vs day 16–0; (●) vs day 16–0 and 30–10; (♦) vs day
16–0, 30–10 and 36–10; (†) vs day 30–10; (‡) vs day 30–10 and 36–16. At the same culture
time: (†) vs OSB-PLA; (‡) vs OSB-PLA, OSB PLA–nHA-20 and OSB PLA–nHA-50; (§)
vs OSB-PLA, OSB PLA–nHA-20, OSB PLA–nHA-50 and OSB-OSC-PLA. (C) Cathepsin
K secretion and (D) TRAP activity by osteoclasts in homotypic and in co-culture system.
For each cell culture condition during the culture time: (*) vs day 24–4; (○) vs day 24–4 and
30–10; (◊) vs day 24–4, 30–10, 36–16; At the same culturetime: (‡) vs OSC–PLA, OSC–
PLA–nHA-20 and OSC–PLA–nHA-50; (§) vs OSC-PLA, OSC–PLA–nHA-20, OSC–
PLA–nHA-50 and OSB–OSC–PLA.
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6.2 Electrospun calcium carbonate fibers
CaCO3 fibers were electrospun from solutions where PVP and Ca(NO3)2·4H2O had been
dissolved into ethanol or 2-ME.II The as-spun fibers were calcined into CaCO3 at 500 °C in
air. Depending on the precursor concentration fibers with diameters ranging from 140 ± 40
to 290 ± 80 nm were obtained (Table 9 and Figure 16). In general a higher Ca(NO3)2
concentration in the electrospinning solution led to an increase in fiber diameter. Solutions
with 2-ME as the solvent could be electrospun into fibers with higher Ca(NO3)2
concentrations compared to the ethanol based solutions, but a higher Ca(NO3)2
concentration was also necessary to obtain continuous fibers.
Table 9. Electrospinning solutions and the obtained CaCO3 fiber diameters.
Solution Polymer solution
m(Ca(NO3)2 ∙ 4H2O)/
V(Polymer solution)
Fiber diameter
E10A 10 wt. % PVP/EtOH 0.025 g/ml 150 ± 40 nm
E10B* 10 wt. % PVP/EtOH 0.050 g/ml *
E12A 12 wt. % PVP/EtOH 0.025 g/ml 210 ± 50 nm
E12B* 12 wt. % PVP/EtOH 0.050 g/ml *
M10A# 10 wt. % PVP/2-ME 0.025 g/ml #
M10B 10 wt. % PVP/2-ME 0.050 g/ml 140 ± 40 nm
M10C 10 wt. % PVP/2-ME 0.10 g/ml 290 ± 80 nm
M12A# 12 wt. % PVP/2-ME 0.025 g/ml #
M12B 12 wt. % PVP/2-ME 0.050 g/ml 140 ± 20 nm
M12C 12 wt. % PVP/2-ME 0.10 g/ml 250 ± 60 nm
amean ± standard deviation *could not be electrospun to fibers in a reliable manner #discontinuous fibers
CaCO3 fibers obtained from the different electrospinning solutions.
In XRD the characteristic reflections of calcite phase were detected regardless of the
solution used in preparation.II Additionally a minor reflection was observed at
approximately 28.4 °2θ but its origin could not be identified. HTXRD revealed that the
calcite phase starts to form around 445 °C and is the only phase present up to 625 °C (Figure
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17). At 655 °C the CaCO3 has partially decomposed into CaO and at 655 °C CaO is the only
phase present. From 745°C onwards more unidentified peaks are observed originating most
likely from a reaction between the fibers and the silicon substrate. TGA in air confirmed the
results for CaCO3 and CaO as distinctive two plateaus were found in the expected
temperature range for both, and the weight loss between these plateaus matched the
expected theoretical weight loss for decomposition of CaCO3 into CaO (Figure 17). A
separate TGA measurement in N2 showed no decomposition step to either CaCO3 or CaO
and a large residual mass remained even after heating up to 800 °C. This suggests that O2
in the calcination atmosphere plays an important role in the decomposition reaction from
Ca(NO3)2/PVP to CaCO3.
HTXRD and TGA analyses of electrospun Ca(NO3)2/PVP fibers. In the HTXRD
the calcite reflections are marked with (*), CaO with (¤), the unknown reflection at 28.4 °2θ
with (#) and the reflections related to the reaction between CaO and the silicon substrate
with (+). The TGA graph shows analysis of the fibers in air and in N2 and the individual
curves of PVP and Ca(NO3)2 ∙ 4H2O in N2 are shown in the inset for comparison.
Although CaCO3 has been studied in literature for bone scaffolds, it should be noted that
the use of CaCO3 is sometimes limited due to its high dissolution in vivo. This might limit
the usability of the CaCO3 nanofibers especially as the dissolution could be further enhanced
by the high surface area in the fibrous samples. No cell culture or other biomedical studies
were performed here on the CaCO3 fibers. Further biomedical studies are needed to discover
the suitability of CaCO3 fibers for implant use. However, the CaCO3 fibers were used as
templates/intermediates in preparation of biomimicking nanocrystalline hydroxyapatite
fibers, which will be further discussed in the following sections.
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6.3 Nanocrystalline hydroxyapatite
A method to prepare nanocrystalline hydroxyapatite nanostructures via conversion of
nanostructured CaCO3 was studied. The conversion process and parameters were examined
in detail in the conversion of ALD CaCO3 thin films, where the effects of temperature, pH
and phosphate concentration were studied while using a constant solution treatment time of
1 h.I The effect of the treatment time was examined in the conversion of fibrous CaCO3
coatings.II It was also demonstrated that the process is capable of converting even very
demanding fibrous CaCO3 nanostructures conformally into nanocrystalline hydroxyapatite.
6.3.1 Thin film coatings
Nanocrystalline hydroxyapatite thin film coatings were prepared via a wet conversion
treatment of ALD CaCO3.I A well-known literature process of Ca(thd)2-O3 was used to
prepare the CaCO3 thin films.199 The conversion process was studied in respect of
temperature, pH and phosphate concentration in the treatment solution. This was done by
treating CaCO3 films deposited at 250 °C with a neutral (0.02, 0.2, 1 or 2 M DAP solution)
or basic (0.2 M DAP in 1M NH3) phosphate solution at RT, 80 or 95 °C.
The conversion attempts of the CaCO3 thin films failed at room temperature regardless of
the solution used because the films dissolved. The solubility of CaCO3 decreases with
increasing temperature and pH and thus higher temperatures and the effect of pH were
examined. Indeed the higher temperatures of 80 and 95 °C resulted in the conversion to
hydroxyapatite phase with both 0.2 M DAP and 0.2 M DAP in 1 M NH3 solutions. With
FESEM a very rough nanocrystalline plate-like crystal structure was seen with strong
resemblance to the hydroxyapatite crystals found in bone. No significant differences
between the temperatures nor basic and neutral solution were observed. In contrast
phosphate concentration had a significant effect with higher concentrations resulting in a
decrease in crystal size and consequently in surface roughness (Figure 18).I This effect was
attributed to the higher nucleation density with increasing concentration. The DAP
concentration had also a significant effect on film quality. Conversion with 0.2 M solutions
reproducibly resulted in homogenous hydroxyapatite thin films. In contrast high
concentrations of 1 and 2 M often resulted in visually nonuniform films whereas films
converted with a low concentration of 0.02 M occasionally peeled partially off the substrate
suggesting that the optimal phosphate concentration is around 0.2 M.
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 FESEM images of films converted with (A) 0.02, (B) 0.2, (C) 1 and (D) 2 M
DAP solutions at 95 °C for 1 h.
ToF-ERDA of a film converted with 0.2 M DAP at 95 °C showed that the elemental
composition is constant throughout the hydroxyapatite film but also that the phase is calcium
deficient with a Ca/P ratio of 1.39 compared to the Ca/P ratio of 1.67 in the stoichiometric
hydroxyapatite (Table 10 and Figure 19).I In terms of major elements the film composition
is described as Ca1.39PO4.50H1.46C0.36 and annealing at 700 °C in N2 changes it into
Ca1.45PO4.23H0.60C0.23. Apart from the large reduction in hydrogen content, the elemental
ratios were not significantly altered by annealing nor were changes observed in the surface
morphology by FESEM. In both samples N, F, Na and Al were found in small amounts
originating from impurities in the ALD process and phosphate solution and thus the impurity
content could be reduced by using higher purity starting chemicals.
Interestingly among the various calcium phosphates the elemental compositions of the films
were closer to those of octacalcium phosphate (OCP, Ca/P=1.33) and tricalcium phosphate
(TCP, Ca/P=1.5) than hydroxyapatite. However, pure TCP phases cannot be prepared from
a solution and OCP hydrolyses to Ca-deficient hydroxyapatite (CDHA,
Ca10-x(HPO4)x(PO4)6-x(OH)2-x, 0<x< 1, Ca/P=1.5-1.67) in hot water.200, 201 The reaction
conditions should favor the formation of the apatite phase and this was verified by XRD
measurements of the films converted in various experimental conditions (Figure 19C).I
HTXRD showed that the apatite phase is thermally stable up to 725 °C in N2 above which
a transformation to TCP occurs at 775 °C. The database reflections of both HA and CDHA
match the peaks observed in XRD. The literature patterns of these two phases are very
similar and cannot be easily separated, especially because due to the nanocrystalline
structure of the films the observed reflection are broad. Hydrothermally prepared CDHA
has been reported to be incorporated in bone remodeling by osteoclastic resorption in vivo
while stoichiometric sintered hydroxyapatite could not be resorbed in the same
conditions.202 Calcium-deficiency could thus be beneficial for cell interactions.
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Table 10. Elemental compositions of hydroxyapatite films as-converted (0.2 M DAP) and
after annealing at 700 °C in N2 for 1 h as measured by ToF-ERDA.
ToF-ERDA depth profiles of hydroxyapatite films (A) as-converted (0.2 M
DAP) and (B) after annealing at 700 °C in N2 for 1 h, and (C) XRD patterns of films
converted with different DAP solutions. The line pattern in (C) is that of the hydroxyapatite.
Although the conversion process was studied in detail using silicon as the substrate, for
clinical applications titanium is a much more relevant material. The excellent conformality
of ALD CaCO3 was preserved in the conversion process and the resulting hydroxyapatite
coating closely followed the surface features of the titanium substrate (Figure 20A and B).I
This demonstrated that the method is suitable for conformal coating of implants with three
dimensional geometries. After Pub. I the conversion process was also applied on medical
grade titanium screws. A homogenous hydroxyapatite coating was obtained all around the
screw and its features (Figure 20C-F). Further proof of the conformality of the solution
conversion process will be presented in the following chapter where conversion of fibrous
CaCO3 to HA is discussed.
FESEM images of a HA film on rough titanium with (A) low and (B) high
magnifications,I and a HA coated Ti screw in (C) optical and (D-F) FESEM images.
Sample
Ca
(at. %)
P
(at. %)
O
(at. %)
H
(at. %)
C
(at. %)
N
(at. %)
F
(at. %)
Na
(at. %)
Al
(at. %)
(A) As-converted 15.8 ± 0.3 11.4 ± 0.3 51.3 ± 0.5 16.7 ± 1.5 4.1 ± 0.2 0.14 ± 0.03 0.15 ± 0.03 0.16 ± 0.05 0.45 ± 0.05
(B) Annealed 18.9 ± 0.5 13.0 ± 0.3 55.0 ± 0.4 7.8 ± 0.3 2.97 ± 0.15 0.17 ± 0.05 1.28 ± 0.07 0.28 ± 0.05 0.57 ± 0.04
51
For bone implant coatings it is essential that the material is not dissolving prior to interacting
with bone cells. The hydroxyapatite coatings were tested for 12 days in the cell culture
medium with no sign of dissolving or being removed in any other way.I The
biocompatibility of the coatings was confirmed by cell cultures studies with human bone
marrow derived osteoclasts. The cell culture protocol used did not allow complete isolation
of the osteoclast precursor cells and thus the cell population used included also a significant
portion of bone marrow stromal cells. The human bone marrow derived cells on the surface
were vital and formed large aggregates. However, no osteoclastic resorption of the surface
was detected within the tested timeframe of 12 days. Otherwise the cell behavior was
comparable to that on reference human bone slices, which showed that the coatings were
not only nontoxic for the cells but they also behaved physiologically on the surfaces.
6.3.2 Fibers and fibrous coatings
The solution conversion of CaCO3 could be applied on fibers similarly to the ALD thin
films. When a self-supporting CaCO3 fiber sheet was immersed into the solution, it had a
tendency to break into smaller flakes. However within these flakes the fibrous nanostructure
of the fiber sheet was preserved and the transformation of the calcite fibers to
nanocrystalline hydroxyapatite was observed throughout the whole sample (Figure 21).II
The calcite substitution with the plate-like hydroxyapatite crystals was visible also in an
increase in fiber diameter and consequently a decrease in pore size. The conformality of the
solution process is thus excellent as it is effective with such demanding three-dimensional
nanostructures.
Self-supporting fibersheets of (A) CaCO3 and (B) nanocrystalline
hydroxyapatite.
As is seen in the breakage of the self-supporting fiber sheets into flakes, the solution
treatment demands sufficient mechanical properties from the sample to be converted. In the
preparation of fibrous coatings another limitation was the insufficient adhesion of the
electrospun fiber layer to the substrate after calcination to CaCO3. The small contact area of
the electrospun fibers with the substrate and the tensions within the fibers can cause the
fiber layer to peel off the substrate already during the electrospinning process if a
sufficiently thick fiber layer is being electrospun. Shrinkage during calcination to CaCO3
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further reduces the adhesion to the substrate and can likewise result in detachment of the
fiber layer. Thus there is a limit how thick fiber layer can be electrospun and calcined
attached to the substrate. However, although the prepared fiber layers were sufficiently thin
not to peel off during calcination to CaCO3, detachment always occurred during the solution
treatment to convert the fibers to hydroxyapatite.
Spin coating and dip coating were therefore used as post-calcination adhesion improving
methods to allow preparation of fibrous nanocrystalline hydroxyapatite coatings (Figure
22).II Ca(NO3)2·4H2O and PVP were dissolved in ethanol and used as coating solution on
the CaCO3 fibers attached to the substrate. The as-prepared layers were then annealed in
500 °C to obtain a pure CaCO3 coating prior to conversion to hydroxyapatite.
The processes for generating fibrous nanocrystalline hydroxyapatite coatings via
either spin or dip coating as the adhesion improving intermediate step.
It was shown that these methods substantially improved the adhesion to the substrate while
still maintaining the fibrous structure of the electrospun layer. Not only were the
strengthened fiber layers able to withstand the wet conversion treatment without peeling off,
but the difference was also observable in the common tape test on the fibrous CaCO3 layers.
Depending on the thickness of the initial fibrous layer, the strengthened layers were either
not removed at all or partially removed from the top (Figure 23) whereas without the
strengthening layer the fibers were always fully removed in the tape test.II The general
approach of using spin and dip coated strengthening layers is useful also for other fiber
coating applications. Later ALD was used to deposit a strengthening CaCO3 layer  on
electrospun CaCO3 on the substrate.
Ca(NO3)2/PVP
solution
CaCO3
fibers
Spin coating
Dip coating
ConversionAnnealingElectrospinning Annealing
Ca(NO3)2/PVP
fibers
Fibrous
hydroxyapatite
coating
Fibrous
CaCO3
coating
CaNO3/PVP
layer within
CaCO3 fibers
53
FESEM images of tape edge areas after the tape test of (A, C) spin and (B, D)
dip coated CaCO3. In A and B the fiber diameters were smaller and the fiber layer thickness
was lower compared to C and D, as seen in the cross section FESEM images of untaped
areas of each sample in the insets. The arrows show the edge separating areas where (T) the
tape had been removed and (UT) not covered by the tape. *Residual glue from the tape.
In the conversion of ALD CaCO3 thin films the samples were always subjected to the DAP
solution for 1 h.I However, in the studies with the fibrous coatings most of the experiments
were done with only five minutes in the solution as this was found to be sufficient for
complete conversion. The reaction is very rapidly proceeding throughout the whole
structure with no signs of CaCO3 reflections detected in XRD of samples treated for 1 and
5 min that have similar hydroxyapatite patterns as a sample subjected for 60 min treatment
(Figure 24).II
XRD patterns of fibrous HA coatings with variable solution treatment times.
The measured samples had a similar area of 1.5 x 1.5 cm2 and were cut from the center area
of the same spin coated fiber sample on silicon wafer. Line pattern is that of hydroxyapatite.
As was seen in the conversion of the self-supporting CaCO3 fiber sheets the DAP solution
treatment of fibrous CaCO3 coatings also resulted in conformal conversion to
hydroxyapatite and in an increase in fiber diameter and decrease in pore size (Figure 25).II
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This could occur even to such extent that the fibrous structure was not seen in FESEM
afterwards if the porosity in the sample prior to conversion had been too low (Figure 25B).
However, the different morphologies presented in Figure 25 demonstrate that the decrease
of porosity can be taken into account so that the end structure can be controlled by a
modification of the thickness of the initial fiber layer and the diameter of fibers in it, i.e. the
electrospinning parameters, as well as by modification of the strengthening layer
preparation process, i.e. the spin and dip coating parameters e.g. the precursor
concentrations in the coating solution.
FESEM images from fibrous hydroxyapatite coatings on silicon converted from
(A, C) spin and (B, D) dip coated CaCO3.
After Pub. II ALD of CaCO3 was also studied for similar strengthening coating of fibers as
the spin and dip coated CaCO3. In comparison to the spin and dip coated fibers, the ALD
coating better retained the original structure of the CaCO3 fiber layer and the film grew all
around fibers and the surface of the substrate (Figure 26A). However, even though the
adhesion improved and facilitated the solution conversion to HA (Figure 26B and C) the
fibers in these coatings were removed in the tape test.
FESEM  images  of  ALD  CaCO3 coated CaCO3 (A) before and (B, C) after
conversion to nanocrystalline hydroxyapatite.
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6.4 Hydroxyapatite fibers
Hydroxyapatite nanofibers were prepared by conventional needle electrospinning and
needleless twisted wire electrospinning (NTWE) of a solution where Ca(NO3)2·4H2O,
TEPO and PVP had been dissolved in 2-ME followed by annealing to form the crystalline
phase and remove the organic components.III,V In contrast, in electroblowing (EB) of
hydroxyapatite EtOH and H2O were used as solvents.IV Regardless of the spinning method
used, the as-spun fibers were calcined to hydroxyapatite at 800 °C in air. The annealed fibers
electrospun with the single needle setup were continuous and around 500 nm in diameter
whereas NTWE resulted in flattened ribbon-like fibers (Figure 27A and B). The diameters
measured for the electroblown and annealed fibers (Figure 27C) were from 200±70 to
330±140 nm depending on the solution and parameters used in the experiment at a relative
humidity of 15±1 %.
 Hydroxyapatite fibers prepared by (A) conventional electrospinning,III (B)
NTWEV and (C) EBIV.
XRD studies revealed that after the annealing at 800 °C hydroxyapatite was the dominant
phase in both the electrospun and electroblown fibers.III,IV CaO and CaCO3 were found as
impurities in the electrospun fibers (Figure 28)III whereas CaO was the only impurity in the
electroblown fibers. In the HTXRD study on an electrospun fiber sample the formation of
the hydroxyapatite phase was first seen at 525 °C. The CaCO3 impurity was observed to
form first at 550 °C and then fully decompose to CaO at 625 °C. CaO was stable up to the
850 °C where the measurement ended (Figure 28).III Thus the CaCO3 found in the fibers
after the calcination at 800 °C must be a product of reactions between CaO and atmospheric
H2O  and  CO2 after the sample had cooled back to room temperature. Indeed, upon
prolonged storage of the electrospun and calcined fibers in air the intensities of the CaO and
CaCO3 reflections were seen to be decreasing and increasing, respectively. A similar
process could occur also for the electroblown fibers under prolonged air exposure.
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XRD and HTXRD analysis of the electrospun fibers.III All the non-assigned
reflections in the XRD origninate from the HA phase whereas peaks assigned to impurity
phases or to multiple phases are marked separately.
SBF studies were performed on the fiber membranes prepared via EB to evaluate the
bioactivity of the HA fibers (Figure 29).IV After 1 and 3 h in solution initial HCA nucleation
had occurred as the fiber surfaces were occupied by multiple seed crystals. Already after
6 h a continuous layer had formed around the fibers suggesting very high bioactivity
induced by the high surface area, small crystal size and mesoporosity present in the fibrous
membrane. Longer treatment times up to 7 days were seen to lead to densification and
increase in thickness of the HCA layer around the fibers while the fibrous structure was
preserved throughout the whole treatment period.
Hydroxyapatite fibers immersed in SBF for 1 h to 7 d. The scale bar is in each
image 1 μm, but note the difference in magnification between the upper and lower rows.
In macrophage cell cultures the tendency of the fibers to initiate inflammatory response was
evaluated by studying cell morphology by FESEM and concentration of pro-inflammatory
cytokines interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) after 2 and 4 days
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of culture (Figure 30).III Bacterial lipopolysaccharide (LPS) was used as a positive control.
In these cell culture studies fiber membranes prepared via the conventional electrospinning
were used. No IL-6 cytokine production was detected on fiber samples without added LPS
while samples with LPS induced cytokine secretion, demonstrating that the fibers alone do
not cause an inflammatory response. However, there were some differences in cytokine
production between the fibers and matrigel and glass reference samples when LPS had been
added. Increased cytokine production in the fibrous samples compared to controls could
suggest the three-dimensional nanostructure to be cell activating when LPS is included to
the sample. TNF-α assay showed more significant differences between the fibers and control
samples. On day 2 no significant differences between fiber and control samples were found,
but on day 4 TNF-α concentration was significantly higher on fiber samples. It has been
suggested that TNF-α, together with many other contributing factors, induces differentiation
of monocytes to osteoclasts, which could indicate that the fiber sheets activate osteoclasts
leading to resorption and bone remodeling.203 At the same time too high TNF-α
concentration can prevent healing and thus in vivo studies are needed to determine the
physiological response.
Cytokine concentrations in the media collected from the samples with cells
cultured on different substrates with and without LPS treatment on the 2nd and 4th day.
Human bone marrow derived osteoclasts (hOCs) cell culture study showed that precursor
cells were able to fuse into multinuclear osteoclast cells on the fiber samples (Figure 31D).III
These osteoclasts were able to resorb the fibers as evident from the excavations formed by
the cells that were comparable to those formed on reference bone slices, thus suggesting
high biocompatibility of the fibers (Figure 31A-C).
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hOCs cultured on electrospun hydroxyapatite fibers visualized with (A–C)
FESEM using different magnifications and (D) fluorescence microscopy to detect the cell
nuclei.
6.5 Scale-up of electrospinning via NTWE, SBS and EB
To overcome the major limitation of the electrospinning method, i.e. the slow production
rate, different upscaling approaches for increasing the throughput of nanofibers were
studied. A new kind of electrospinning tool “Needleless twisted wire electrospinning
(NTWE) setup” was developed, which relies on self-formation of multiple electrospinning
jets on a twisted wire surface.V It was used to prepare polymeric PVP and inorganic
hydroxyapatite and bioactive glass fibers while EBIV and SBSIV were studied for the
preparation of hydroxyapatite fibers.
6.5.1 Characteristics of the NTWE processes
The schematic design of the developed NTWE setup was depicted in the experimental
section (Figure 12).V Similarly to the needle electrospinning the NTWE processes can be
controlled via interconnected solution and operating parameters. The solution parameters
are the same as in the conventional needle electrospinning, but the operating parameters
differ somewhat. Similar to conventional electrospinning the most significant operating
parameters include the feed rate of the solution, the voltage and the distance, which in this
case is that between the wire and the collector, i.e. the radius of the collector. In addition to
those, the twist, diameter and length of the wire as well as the friction between the polymer
solution and the wire also affect the NTWE process.
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For each spinning process the wire properties, voltage, viscosity and feed rate of the solution
needed to be optimized so that a continuous flow of solution was achieved for the whole
length of the wire.V Thus jet initiation points were formed all around the whole length of
the wire resulting in the formation of a continuous fiber mat on the cylindrical collector.
The excess of solution was collected into a container at the end of the wire. If the feed of
the solution was not sufficient to maintain a continuous flow, gel formation was observed
at the lower part of the wire. Drying due to evaporation of solvent in itself is an inevitable
part of the tool and will eventually force to interrupt the process for cleaning the wire.
However, the studies indicated that with optimized parameters over 20 ml of the
electrospinning solution could be spun without any complications.
Another effect caused by the evaporation of the solvent is the increase in viscosity of the
solution at the lower parts of the wire. This translates to a small increase in fiber diameter
for the fibers collected at the lower parts when compared to the fibers collected at the upper
parts of the collector. However, the effect is quite small as was shown when the diameters
of PVP fibers collected from different heights of the electrospun fiber sheet were compared
(Table 11).V For instance for the fibers electrospun from 12.5 wt.% PVP/EtOH solution the
average fiber diameter increased only from 530 ± 82 to 582 ± 70 nm when the top 10 and
bottom 10 cm of the collected fiber sheet were compared.
Table 11. Fiber diameters measured from samples taken from different heights of the fiber
sheet electrospun from 10, 12.5 and 15 wt. % PVP/EtOH solutions.
10 wt.% PVP/EtOH 12.5 wt.% PVP/EtOH 15 wt.% PVP/EtOH
Viscosity 0.21 Pa∙s 0.34 Pa∙s 2.36 Pa∙s
Position Diameter (nm) N Diameter (nm) N Diameter (nm) N
Top 371 ± 68 84 530 ± 82 78 1095 ± 266 42
Center 389 ± 66 83 581 ± 69 80 1071 ± 248 46
Bottom 431 ± 81 82 582 ± 70 83 1129 ± 237 42
All 397 ± 76 249 565 ± 77 241 1097 ± 250 130
Diameters are represented as mean ± standard deviation, N = number of measured fibers.
6.5.2 The characteristics of the SBS and EB processes
Solution blow spinning (SBS) and electroblowing (EB) were used to prepare fibers from a
coaxial setup that added high velocity gas flow to the conventional electrospinning design
(Figure 12).IV This enabled the use of significantly higher feed rates up to 30 ml/h as
compared to the conventional electrospinning because in the SBS and EB processes the gas
flow acted as the main force in drawing the polymer solution from the needle tip into a jet.
However, the electrostatic force present in EB was found to be critical during the jet flight
to obtain high quality homogeneous fiber membranes. The fiber sheets prepared by SBS
contained a lot of very large beads and particles after annealing the fibers to hydroxyapatite
(Figure 32D). A lot of solvent droplets arrived at the back of the collector during the process
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resulting in holes in the fiber sheet and reduced yield. The fibers were also difficult to extract
as continuous sheets from the collector. In contrast, EB with the spinneret set at 15 kV, but
otherwise with the same conditions as in the SBS experiments, led to a homogenous
randomly oriented fiber network that could be collected as large sheets, which retained their
morphology after annealing to hydroxyapatite (Figure 32A-C).IV Thus, it is clear that the
additional jet thinning provided by the electrostatic repulsion within the fibers during the jet
flight significantly improved the overall fiber quality.
Low magnification FESEM images of electroblown fibers (A) as-spun and (B)
after annealing, (C) folded fiber sheets after annealing on a 6 inch silicon wafer and (D) low
magnification FESEM image of solution blown fibers after annealing.
6.5.3 Productivity of the scale-up processes
The NTWE and EB provided an easy and straightforward way for increasing production
rate in the lab scale where most of the electrospinning research is performed via the single
needle processes resulting in typical production rates around only 0.1 g/h depending on the
process. At best the NTWE tool prepared a 1.15 g fiber sheet from 22 ml of 10 wt.
PVP/EtOH solution using a feed rate of 100 ml/h.V This took 13.2 min and equals to a
production rate of 5.23 g/h. In comparison in the single needle electrospinning of 10 wt. %
PVP/EtOH the production rate was only 0.14 g/h and thus it would take 8.2 h to produce a
comparable 1.15 g PVP fiber sheet.
Transferring the single needle electrospinning process of hydroxyapatite to the NTWE tool
was not as straightforward as in the case of bare PVP/EtOH solutions. Not as high
hydroxyapatite precursor concentrations could be used in NTWE as in the single needle
electrospinning, like the process used in Pub. III. To take this into account, the production
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rates of optimized processes for both methods were compared instead of using a solution
with low hydroxyapatite precursor concentrations for both. This favors the single needle
process in terms of higher hydroxyapatite precursor content per volume of the electrospun
solution, but still at best over a 15 fold increase in production rate from 0.09 to 1.40 g/h of
hydroxyapatite fibers was obtained with NTWE.V Production rates in EB of HA varied from
0.39 to 1.38 g/h depending on the solution feed rated in the experiment and precursor
concentration within the solution.IV The highest production rate of 1.38 g/h obtained for HA
fibers with EB was comparable to that obtained with NTWE.
Although NTWE and EB approaches offer significant improvements in the lab scale
productivity, industrial scale production would require even higher rates combined with
continuously running processes. As such the demonstrated NTWE tool is incapable of
filling these requirements. Some increase could be obtained by increasing the length of the
wire as well as increasing the number of the collector-wire pairs. The major limitation of
drying of the solution on the wire is more difficult to avoid. To adapt with this two possible
modifications to the setup were suggested that would prevent the drying from affecting the
process (Figure 33).V These rely on designs where the wire surface from which the fibers
are spun is constantly refreshed with the aid of rotating coils. This can be done either with
a combination of a feed and a collector coil (Figure 33A) or a fully closed wire loop (Figure
33B). Thus the dried polymer film on the wire would be removed from the system prior to
having an adverse effect on the fiber formation. This would also improve fiber homogeneity
between different heights of the collector. The design in Figure 33B incorporates a washing
step to the closed wire system thus enabling continuously running processes and continuous
collection and reuse of the excess polymer solution. Also the collector could be modified to
enable continuous roll-to-roll fiber sheet collection.
Schematic diagrams of the proposed modifications to the NTWE setup for
industrial scale production. In (A) the wire is constantly fed into and drawn out of the system
by rotating coils, which constantly refreshes the surface on which the polymer solution is
fed on. (B) depicts a setup with a continuously moving closed wire system including an
integrated washing step for removal of dried polymer from the wire.
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In contrast electroblowing can as such fulfill the requirements of continuously running
processes as with optimized processes it does not suffer from clogging of any sorts and thus
a process can be kept running as long as solution is fed to the spinneret.IV However, similarly
to NTWE further improvements in production rate are required for industrial scale use.
Electroblowing from multiple spinnerets could be a viable alternative to increase the
productivity. As gas flow is the main drawing force in EB, it should not suffer from as
severe suppression of jet formation from individual needles as is seen in multineedle
electrospinning due to the interfering electric fields of adjacent needles. However, as
discussed in previous sections, further studies are still required to evaluate the viability of
multispinneret EB approach for industrial scale nanofiber preparation.
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7 Conclusions and outlook
There is a growing need for better bone implants and scaffolds to improve the quality of life
of patients and to reduce the cost of orthopedic surgery. The key for better implants lies in
the surface chemistry and topography that should support bone cell functions to integrate
the structure into bone. At best bone defects can be healed by temporary bone scaffolds that
integrate the structure into the natural bone remodeling cycle, i.e. the structure provides a
favorable environment for cell interactions to facilitate new bone formation while being
degraded at the same time. Combining the favorable mechanical, structural and chemical
properties is the main challenge in preparation of bone implants and scaffolds.
Thus far ALD has not been widely used or studied for bioactive coatings. However, for
coating of surfaces tuned down to the nanoscale for optimal cellular response, and even
complex three-dimensional implants and scaffolds, ALD has very favorable characteristics
as its conformality and atomic layer level thickness control are unmatched by any other
method. The conversion of atomic layer deposited CaCO3 in phosphate solution is very
simple method to produce biomimetic plate-like hydroxyapatite thin films. The use of the
solution conversion circumvents the problems previously met in ALD of hydroxyapatite,
i.e. complex stoichiometry control and need for high temperature post-deposition annealing,
while preserving the conformality characteristics of ALD. The combination of ALD and
solution conversion is promising for three-dimensional scaffolds, though it is restricted by
the thermal requirements of the ALD CaCO3 process. Development of new lower
temperature precursors and processes for the ALD of CaCO3 would  widen  the  range  of
materials the hydroxyapatite coatings can be applied on.
Nanofibrous materials have many properties that make them well suited for bone scaffolds.
They have high surface area and porosity and structural similarity with the fibrous bone
tissue. Multiple literature reports demonstrate very favorable interaction with bone cells
both in vitro and in vivo for various different electrospun bioceramics and biocomposite
nanofibers. The fiber membranes can also be modified or assembled into macrostructures
to add macroporosity; a feature normally missing from as-spun fiber membranes.
Many promising results were obtained in the electrospinning studies. The electrospun
nHA/PLA fibers presented a suitable environment for interactions with bone cells in an in
vitro co-culture cell study with osteoblast and osteoclast progenitor cells. The co-culture
methodology models the in vivo environment better than the more frequently used cell
cultures with osteoblast precursor cells or mature osteoblasts. The electrospun
hydroxyapatite fibers were subjected to a human bone marrow derived osteoclast cell
culture study and it was shown that the cells could fuse into multinuclear osteoclasts that
are capable of resorbing the HA nanofiber network. Thus it could be possible to include the
fibers into the bone remodeling cycle. The CaCO3 fibers had not been electrospun
previously and via the phosphate solution conversion method they offer a new route for
preparation of nanocrystalline HA fibers with potentially improved properties. The
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conformality of the solution conversion method is highlighted by its ability to preserve the
fibrous shape. However, no cell culture studies have been performed on the converted HA
but the increased surface area and bone-like crystal structure could lead to better biological
properties compared to HA fibers made directly by electrospinning and calcination of fibers.
The main limitation of the conventional electrospinning for industrial scale production lies
in its slow production rate. EB and the new NTWE method developed in this thesis were
shown to be capable of producing high quality fiber networks comparable to that of
electrospinning with significantly improved production rates. The high bioactivity of EB
HA nanofibers was verified in simulated body fluid immersion experiments and found out
to be comparable to literature reports on SBF studies with electrospun HA.
Some open questions still remain for all the prepared fibrous materials. More thorough
examination of the mechanical and biological properties, including in vivo studies, should
be conducted. Also, although the electrospun and electroblown HA fibers showed favorable
biological properties, further studies are required on that how to incorporate the crystalline
fibers into scaffolds as the HA fibers alone are too brittle for most applications. Significant
advancements in productivity from the conventional electrospinning were achieved with
NTWE and EB, but both still need further development to reach industrial scale
productivity. In particular, simultaneous EB from multiple spinnerets and modifying the
NTWE setup to enable continuously running processes need to be studied.
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